Automatic drug administration apparatus

Abstract

An automatic drug administration apparatus (300), comprising: a shielding box (301), a first shielding chamber (302) being formed in the shielding box (301); and a reagent injection assembly (500), at least part of the reagent injection assembly (500) being provided in the first shielding chamber (302), the reagent injection assembly (500) being suitable for connecting to a reagent bottle (30) and an infusion member, the reagent injection assembly (500) being used for communicating the reagent bottle (30) and the infusion member, and the reagent injection assembly (500) being further used for driving a reagent in the reagent bottle (30) to flow along the reagent injection assembly (500).

Description

Automatic drug delivery device

[0001] Cross-reference to related applications

[0002] The present application is based on and claims priority to Chinese Patent Application No. 202410648770.0, filed on May 23, 2024, the entire contents of which are hereby incorporated by reference into the present application. TECHNICAL FIELD

[0003] The present application relates to the technical field of reagent injection, and in particular to an automatic drug delivery device. BACKGROUND

[0004] In related technologies, drugs for tumor diagnosis and treatment are developing rapidly, among which radioactive drugs are emerging. Radioactive drugs refer to a special type of drugs containing radionuclides and used for medical diagnosis and treatment. Radioactive drugs pose radiation hazards to workers and have the risk of environmental exposure. The existing injection system requires workers to connect the syringe with the medicine bottle, which is difficult to avoid radiation hazards. SUMMARY

[0005] The present application aims to at least partially solve one of the technical problems in the related art.

[0006] To this end, one object of the present application is to provide an automatic drug delivery device.

[0007] The automatic drug delivery device according to an embodiment of the present application comprises a shielding box body, the shielding box body forms a first shielding cavity; a reagent injection assembly, at least part of the reagent injection assembly is arranged in the first shielding cavity, the reagent injection assembly is adapted to be connected with a reagent bottle and a transfusion piece, the reagent injection assembly is used to communicate the reagent bottle and the transfusion piece, and the reagent injection assembly is also used to drive the reagent in the reagent bottle to flow along the reagent injection assembly.

[0008] According to the automatic drug delivery device, the shielding box is used for carrying the whole automatic drug delivery device, at least part of the reagent injection assembly is arranged in the first shielding cavity, the reagent injection assembly is shielded, the radiation harm of the reagent in the reagent injection assembly to the staff and the patient is reduced, the reagent injection assembly is used for connecting the reagent bottle and the infusion implement, the reagent injection assembly is also used for driving the reagent in the reagent bottle to flow to the infusion implement along the reagent injection assembly, automatic taking, transmission and injection of the reagent are realized, the contact between the staff and the reagent is greatly reduced in the injection process, the radiation harm of the reagent to the staff is further reduced, and the personal safety of the staff and the patient is effectively ensured. On the other hand, the automatic drug delivery device can be used for sequentially injecting a plurality of patients, the injection efficiency is improved, and the injection cost is reduced. According to the automatic drug delivery device, the shielding box is used for carrying the whole automatic drug delivery device, at least part of the reagent injection assembly is arranged in the first shielding cavity, the reagent injection assembly is shielded, the radiation harm of the reagent in the reagent injection assembly to the staff and the patient is reduced, the reagent injection assembly is used for connecting the reagent bottle and the infusion implement, the reagent injection assembly is also used for driving the reagent in the reagent bottle to flow to the infusion implement along the reagent injection assembly.

[0009] According to the automatic drug delivery device, the shielding box is used for carrying the whole automatic drug delivery device, at least part of the reagent injection assembly is arranged in the first shielding cavity, the reagent injection assembly is shielded, the radiation harm of the reagent in the reagent injection assembly to the staff and the patient is reduced, the reagent injection assembly is used for connecting the reagent bottle and the infusion implement, the reagent injection assembly is also used for driving the reagent in the reagent bottle to flow to the infusion implement along the reagent injection assembly, automatic taking, transmission and injection of the reagent are realized, the contact between the staff and the reagent is greatly reduced in the injection process, the radiation harm of the reagent to the staff is further reduced, and the personal safety of the staff and the patient is effectively ensured. On the other hand, the automatic drug delivery device can be used for sequentially injecting a plurality of patients, the injection efficiency is improved, and the injection cost is reduced.

[0010] Additional aspects and advantages of the application will be set forth in part in the description which follows, and in part will become apparent to those skilled in the art upon examination of the following description and drawings. BRIEF DESCRIPTION OF DRAWINGS

[0011] Fig. 1 is a schematic diagram of the external structure of the automatic drug delivery device according to the first embodiment of the application;

[0012] Fig. 2 is a schematic diagram of the internal structure of the automatic drug delivery device according to the first embodiment of the application;

[0013] Fig. 3 is a schematic diagram of the structure of the reagent injection device according to the embodiment of the application;

[0014] Fig. 4 is a structural schematic diagram of a reagent delivery device according to an embodiment of the present application;

[0015] Fig. 5 is a structural schematic diagram of an external structure of an automatic drug delivery device according to a second embodiment of the present application;

[0016] Fig. 6 is a structural schematic diagram of an internal structure of the automatic drug delivery device according to the second embodiment of the present application;

[0017] Fig. 7 is a structural schematic diagram of the automatic drug delivery device according to the second embodiment of the present application from another perspective;

[0018] Fig. 8 is a structural schematic diagram of an external structure of an automatic drug delivery device according to a third embodiment of the present application;

[0019] Fig. 9 is a structural schematic diagram of an internal structure of the automatic drug delivery device according to the third embodiment of the present application;

[0020] Fig. 10 is an enlarged schematic diagram of A in Fig. 9. DETAILED DESCRIPTION

[0021] Embodiments of the present application are described in detail below with reference to the accompanying drawings, in which the same or similar components have the same or similar designations and functions throughout, and embodiments described below are exemplary and are intended for explanation of the present application, and are not to be construed as limiting the present application.

[0022] An automatic drug delivery device 300 according to an embodiment of the present application is described below with reference to Figs. 1-10, in which the reagent can be a liquid reagent or a solid reagent, the liquid reagent can be a liquid drug or other chemical liquid reagent, and the solid reagent can be a powdered drug, and the present application is described by taking the reagent as a drug, which can be a radioactive drug, physiological saline, etc. The radioactive drug refers to a special drug containing a radionuclide and used for medical diagnosis and treatment, and can be a drug for tumor diagnosis and treatment.

[0023] As shown in Figs. 1-10, the automatic drug delivery device 300 according to an embodiment of the present application comprises a shielding box 301, the shielding box 301 being formed with a first shielding cavity 302; and a reagent injection assembly 500, at least a part of the reagent injection assembly 500 being arranged in the first shielding cavity 302, the reagent injection assembly 500 being adapted to be connected with a reagent bottle 30 and a transfusion member, the reagent injection assembly 500 being used to communicate the reagent bottle 30 and the transfusion member, and the reagent injection assembly 500 being further used to drive the reagent in the reagent bottle 30 to flow along the reagent injection assembly 500.

[0024] Generally, the reagent injection assembly 500 is adapted to be connected with the reagent bottle 30 and the transfusion member on an animal living body.

[0025] Animal living body refers to a living being with life characteristics, multicellular structure, heterotrophic nutrition mode and movement ability, belongs to animal kingdom, and includes animal body and human body and other animal individuals in a life activity state. The present application is illustrated by injecting radioactive drugs into the human body, but the present application is not limited to this use scenario, and can also be used in animal experiment scenarios.

[0026] In the clinical injection use scenario, the reagent injection assembly 500 is suitable for being connected with the reagent bottle 30 and the infusion member on the human body; in the animal experiment, the reagent injection assembly 500 is suitable for being connected with the reagent bottle 30 and the infusion member on the animal.

[0027] Among them, the infusion member refers to various medical devices and tools for infusing drugs or liquids into the patient's body, including but not limited to infusion needles, indwelling needles, injection needles, needle tips, etc. The main function of these devices is to infuse drugs or liquids into the patient's body through different routes (such as intravenous, subcutaneous, etc.), in order to achieve the purpose of treatment, fluid or nutritional support, etc. The present application is illustrated by taking the infusion member as an indwelling needle, which is left in the blood vessel after puncturing the vein, the steel needle is withdrawn, and only the tube needs to be sealed after infusion, and the tube can be left for a long time, reducing the damage to the patient caused by multiple infusions.

[0028] The automatic drug delivery device 300 comprises a shielding box 301, which is used to carry the automatic drug delivery device 300. The shielding box 301 can be made of shielding materials, such as lead plates, iron plates, etc. to form a first shielding cavity 302. Further, the shielding box 301 can be defined by a lead plate surface coated with an alloy material to form the first shielding cavity 302, which has shielding effectiveness and can shield radiation.

[0029] At least part of the reagent injection assembly 500 is located in the first shielding cavity 302, for example, one half of the reagent injection assembly 500 can be located in the first shielding cavity 302, or one third of the reagent injection assembly 500 can be located in the first shielding cavity 302, or the entire structure of the reagent injection assembly 500 can be located in the first shielding cavity 302, but the present application is not limited thereto. The reagent injection assembly 500 can also have other proportions located in the first shielding cavity 302, as long as at least part of the reagent injection assembly 500 is located in the first shielding cavity 302. As an embodiment of the application, part of the reagent injection assembly 500 can be located outside the first shielding cavity 302, which communicates with the infusion member in the patient's body. As another embodiment of the application, a separate pipeline can be used to communicate the reagent injection assembly 500 in the first shielding cavity 302 with the infusion member in the patient's body.

[0030] The reagent injection assembly 500 is adapted to be connected with the reagent bottle 30 and the infusion device, so that the reagent injection assembly 500 is used to connect the reagent bottle 30 and the infusion device, and the reagent injection assembly 500 is also used to drive the reagent in the reagent bottle 30 to flow along the reagent injection assembly 500, thereby achieving the effect that the reagent in the reagent bottle 30 flows to the patient's body in sequence through the reagent injection assembly 500 and the infusion device (for example, the effect that the radiopharmaceutical flows to the patient's body in sequence through the reagent injection assembly 500 and the infusion device, or the effect that the physiological saline flows to the patient's body in sequence through the reagent injection assembly 500 and the infusion device, or the effect that the physiological saline flows along the reagent injection assembly 500 to discharge the air in the reagent injection assembly 500). In addition, the reagent injection assembly 500 can also be connected with the infusion device on the animal body, so that the reagent injection assembly 500 is used to connect the reagent bottle 30 and the infusion device, and the reagent injection assembly 500 is also used to drive the reagent in the reagent bottle 30 to flow along the reagent injection assembly 500, thereby achieving the effect that the reagent in the reagent bottle 30 flows to the animal body in sequence through the reagent injection assembly 500 and the infusion device (for example, the effect that the radiopharmaceutical flows to the animal body in sequence through the reagent injection assembly 500 and the infusion device, or the effect that the physiological saline flows to the animal body in sequence through the reagent injection assembly 500 and the infusion device, or the effect that the physiological saline flows along the reagent injection assembly 500 to discharge the air in the reagent injection assembly 500).

[0031] In this way, the automatic taking, transmission and injection of the reagent can be achieved, so that the contact between the staff and the reagent during the injection process is greatly reduced, thereby further reducing the radiation hazard of the reagent to the staff, and effectively protecting the personal safety of the staff and the patient. On the other hand, a plurality of reagent bottles 30 can be placed in the automatic drug delivery device 300, and the automatic drug delivery device 300 can be used to sequentially inject a plurality of patients or animals, thereby improving the injection efficiency and reducing the injection cost.

[0032] It can be explained that the reagent bottle 30 can be a container for containing the reagent, for example, the reagent bottle 30 can be a bottle or a bag, and further, the reagent bottle 30 can be a vial and a saline bag.

[0033] According to some embodiments of the present application, the shielding box 301 is movable, which can facilitate the staff to move the shielding box 301 in front of the patient's bed for operation, thereby facilitating the patient to receive the injection.

[0034] According to some embodiments of the present application, the infusion member can be a retention needle or an intravenous infusion needle, which can be reasonably selected according to actual conditions. When only a single injection is needed for the patient, the intravenous infusion needle can be selected. When multiple injections are needed for the patient, the retention needle can be selected. The retention needle can be retained in the vein of the patient for multiple days, avoiding the need for repeated puncture, reducing the pain and discomfort of the patient, and also reducing the work burden of medical staff.

[0035] According to some embodiments of the present application, as shown in FIG. 3, the reagent injection assembly 500 includes a reagent delivery device 100, the reagent delivery device 100 being adapted to be connected with the reagent bottle 30 and the infusion member, the reagent delivery device 100 being used to communicate the reagent bottle 30 and the infusion member, a reagent injection device 200, the reagent injection device 200 being arranged in the first shielding cavity 302, the reagent injection device 200 cooperating with the reagent delivery device 100 to drive the reagent in the reagent bottle 30 to flow along the reagent delivery device 100.

[0036] The reagent conveying device 100 is suitable for being connected with the reagent bottle 30 and the infusion member, and the reagent conveying device 100 is used to connect the reagent bottle 30 and the infusion member, so that the reagent in the reagent bottle 30 can be conveyed to the infusion member through the reagent conveying device 100 for injection to the patient. The reagent injection equipment 200 is arranged in the first shielding cavity 302, for example, the reagent injection equipment 200 and the shielding box 301 can be connected through clamping connection, or the reagent injection equipment 200 and the shielding box 301 can be connected through bolt connection, but the application is not limited to this, the reagent injection equipment 200 and the shielding box 301 can also be connected through other ways, as long as the reagent injection equipment 200 is arranged in the first shielding cavity 302. In this way, the first shielding cavity 302 can shield the reagent injection equipment 200, and the first shielding cavity 302 can also cover the reagent injection equipment 200 to play a protection role, thereby reducing the risk of collision and scratching of the reagent injection equipment 200 by external objects, and further improving the service life of the automatic drug delivery equipment 300. The reagent injection equipment 200 cooperates with the reagent conveying device 100 to drive the reagent in the reagent bottle 30 to flow along the reagent conveying device 100, so that the reagent can be conveyed in the reagent conveying device 100 (for example, radioactive drugs flow from the reagent conveying device 100, the infusion member to the patient's body in turn, or physiological saline flows from the reagent conveying device 100, the infusion member to the patient's body in turn, or physiological saline discharges air along the reagent conveying device 100). Therefore, the shielding box 301 is used to move the automatic drug delivery equipment 300, which can facilitate the staff to move the automatic drug delivery equipment 300 to the patient's bed for operation, so that the patient can receive injection; the reagent bottles 30 arranged in the shielding box 301 can exist simultaneously, and a plurality of patients can be injected in turn at one time, so that the injection efficiency is improved, and the injection cost is reduced. By arranging the reagent bottle 30, the reagent conveying device 100 and the reagent injection equipment 200 in the first shielding cavity 302, the radiation harm of the reagent to the staff and the patient can be reduced, and through the cooperation of the reagent conveying device 100 and the reagent injection equipment 200, the automatic drug delivery equipment 300 can realize automatic taking, transmission and injection of the reagent, so that the contact between the staff and the reagent during injection can be greatly reduced, thereby further reducing the radiation harm of the reagent to the staff, and the personal safety of the staff and the patient can be effectively guaranteed.

[0037] According to some embodiments of the present application, as shown in FIG. 3, the reagent injection device 200 is provided with a plurality of driving pumps 23, the reagent delivery device 100 comprises a plurality of delivery pipelines 20 and a plurality of reagent bottles 30, each of the plurality of delivery pipelines 20 is adapted to communicate with a corresponding reagent bottle 30, the plurality of delivery pipelines 20 are all in communication with the plurality of reagent bottles 30, each of the plurality of delivery pipelines 20 is matched with a corresponding driving pump 23 to make the reagent in the corresponding reagent bottle 30 flow into the plurality of delivery pipelines 20 or another delivery pipeline 20, and the plurality of delivery pipelines 20 are all in communication with the plurality of reagent bottles 30.

[0038] In the present application, the reagent injection device 200 can be provided with a plurality of driving pumps 23, for example, the reagent injection device 200 can be provided with two, three, four or the like number of driving pumps 23, but the present application is not limited thereto, and the reagent injection device 200 can also be provided with other number of driving pumps 23, as long as the reagent injection device 200 is provided with a plurality of driving pumps 23. The driving pump 23 can be a peristaltic pump, a screw pump or the like, and the present application takes the peristaltic pump as an example for description. The peristaltic pump has sufficient self-suction, good sealing performance and high precision, thereby improving the performance of the reagent injection device 200, and the peristaltic pump is easy to maintain, thereby reducing the maintenance cost of the reagent injection device 200.

[0039] The reagent delivery device 100 comprises a plurality of delivery pipelines 20 and a plurality of reagent bottles 30, for example, the reagent delivery device 100 can comprise two, three, four or the like number of delivery pipelines 20, but the present application is not limited thereto, and the reagent delivery device 100 can also comprise other number of delivery pipelines 20, as long as the reagent delivery device 100 comprises a plurality of delivery pipelines 20. Each of the plurality of delivery pipelines 20 is adapted to communicate with a corresponding reagent bottle 30, for example, the delivery pipeline 20 and the reagent bottle 30 can be connected by a metal pin 42 to make the delivery pipeline 20 communicate with the reagent bottle 30, thereby enabling the reagent in the reagent bottle 30 to enter the corresponding delivery pipeline 20, wherein the reagent delivery scheme of the delivery pipeline 20 can be set by a software system to control the driving pump 23 to work according to different patient infusion schemes, thereby facilitating and accurately taking the reagent without manual taking of the reagent, avoiding the waste of reagent due to operation errors when manually taking the reagent, and when the reagent is toxic or radioactive, using the delivery pipeline 20 to take the reagent can also avoid the harm of toxic or radioactive reagent to the health of the workers.

[0040] The manifold pipe 10 and the plurality of delivery pipes 20 can be integrally formed, or the manifold pipe 10 and the plurality of delivery pipes 20 can also be assembled through the joint 15, for example, the manifold pipe 10 and the plurality of delivery pipes 20 can also be assembled through a luer joint, so that the manifold pipe 10 and the plurality of delivery pipes 20 are all in communication, thereby enabling the reagent in each reagent bottle 30 to enter the manifold pipe 10 through the corresponding delivery pipe 20, thereby facilitating and accurately taking the reagent without manual taking of the reagent, which can avoid the waste of reagent due to operation errors when manually taking the reagent, and when the reagent is toxic or radioactive, using the delivery pipe 20 and the manifold pipe 10 to cooperate to take the reagent can also avoid the harm of toxic and radioactive reagents to the health of the workers. The application is described by taking the manifold pipe 10 and the plurality of delivery pipes 20 integrally formed as an example. The integrally formed pipe can reduce the risk of liquid leakage and contamination of the liquid caused by the liquid passing through multiple components, thereby improving the safety and reliability of the reagent delivery device 100, thereby effectively protecting the safety of the patient.

[0041] As shown in FIG. 4, each delivery pipe 20 can be provided with a limiting portion 44. When each delivery pipe 20 cooperates with the corresponding drive pump 23, the limiting portion 44 can limit the delivery pipe 20, thereby reducing the risk of the delivery pipe 20 falling off the drive pump 23, and thereby improving the safety and reliability of the reagent delivery device 100.

[0042] Each delivery pipe 20 cooperates with the corresponding drive pump 23 to make the reagent in the corresponding reagent bottle 30 flow into the manifold pipe 10 or another delivery pipe 20. The dose of the reagent delivered by the delivery pipe 20 can be set by a software system according to the infusion scheme of different patients to control the operation of the drive pump 23, thereby the drive pump 23 pumps the reagent in the corresponding reagent bottle 30 into the corresponding delivery pipe 20, and the reagent in the delivery pipe 20 flows into the manifold pipe 10 or another delivery pipe 20. The manifold pipe 10 is adapted to communicate with an infusion member, for example, as shown in FIG. 4, the manifold pipe 10 and the infusion member can be connected and communicated through the joint 15. The joint 15 can be a luer joint. The infusion member is inserted into the patient's body, which can enable the reagent to be delivered to the patient's body through the infusion member to complete the infusion. Thus, the reagent taking process of the reagent injection equipment 200 of the application is accurate, convenient and efficient, not only saving the cumbersome steps of manual taking of reagent, but also avoiding waste of reagent due to manual errors, and avoiding harm of toxic and radioactive reagents to the health of workers.

[0043] As an embodiment of the present application, there can be two delivery pipelines 20, one of which delivers the radiopharmaceutical and the other of which delivers the normal saline. The normal saline can be delivered through the corresponding delivery pipeline 20 first, for the purpose of emptying the air and bubbles in the pipelines, and then the radiopharmaceutical is delivered through the corresponding delivery pipeline 20 to the patient's body. After the delivery of the radiopharmaceutical is completed, the normal saline is delivered again through the corresponding delivery pipeline 20 to the patient, so as to flush the radiopharmaceutical in the manifold pipeline 10, so that the residual radiopharmaceutical in the manifold pipeline 10 is delivered to the patient's body. The injection is stopped immediately after the residual radiopharmaceutical is delivered to the patient's body, so as to maximize the accuracy of the drug injection and the activity of the drug, thereby improving the injection accuracy of the automatic drug delivery device 300.

[0044] Further, in the scenario of radiopharmaceutical delivery, four stages need to be experienced, which are the first air bubble emptying stage, the second air bubble emptying stage, the drug delivery stage and the drug delivery completion stage. In the first air bubble emptying stage, the manifold pipeline 10 is not communicated with the patient, and the driving pumps 23 (usually peristaltic pumps) on the delivery pipeline 20 for delivering the radiopharmaceutical and the delivery pipeline 20 for delivering the normal saline are started at the same time, so as to control the normal saline to flow from the delivery pipeline 20 for delivering the normal saline to one end of the delivery pipeline 20 for delivering the radiopharmaceutical, so as to empty the air bubbles in the pipelines. In the second air bubble emptying stage, the manifold pipeline 10 is not communicated with the patient, the corresponding driving pump 23 (usually a peristaltic pump) on the delivery pipeline 20 for delivering the radiopharmaceutical stops working, and the corresponding driving pump 23 (usually a peristaltic pump) on the delivery pipeline 20 for delivering the normal saline is started, so as to control the normal saline to flow to the manifold pipeline 10, and empty the air bubbles in the manifold pipeline 10. In the drug delivery stage, the manifold pipeline 10 is communicated with the patient, the corresponding driving pump 23 (usually a peristaltic pump) on the delivery pipeline 20 for delivering the normal saline stops working, and the corresponding driving pump 23 (usually a peristaltic pump) on the delivery pipeline 20 for delivering the radiopharmaceutical is started, so as to control the radiopharmaceutical to flow to the manifold pipeline 10 and be input into the patient's body. In the drug delivery completion stage, the corresponding driving pump 23 (usually a peristaltic pump) on the delivery pipeline 20 for delivering the radiopharmaceutical stops working, and the corresponding driving pump 23 (usually a peristaltic pump) on the delivery pipeline 20 for delivering the normal saline is started, so as to control the normal saline to flow to the manifold pipeline 10, so as to input the residual drug in the manifold pipeline 10 into the patient's body. The injection is stopped immediately after the residual radiopharmaceutical is delivered to the patient's body, so as to maximize the accuracy of the drug injection and the activity of the drug, thereby improving the injection accuracy of the automatic drug delivery device 300.

[0045] According to some embodiments of the present application, as shown in FIG. 3, the reagent delivery device 100 further comprises a confluence block 13, the confluence block 13 is internally formed with a confluence cavity 14, the confluence block 13 is connected with the confluence pipeline 10 and the plurality of delivery pipelines 20, the confluence cavity 14 is in communication with the confluence pipeline 10 and the plurality of delivery pipelines 20, and the confluence block 13 is fixedly arranged on the reagent injection equipment 200.

[0046] The reagent delivery device 100 can be provided with the confluence block 13, the confluence block 13 can be fixedly arranged on the reagent injection equipment 200, for example, the confluence block 13 and the reagent injection equipment 200 can be fixedly connected through clamping, or the confluence block 13 and the reagent injection equipment 200 can be fixedly connected through bonding, but the present application is not limited thereto, the confluence block 13 and the reagent injection equipment 200 can also be fixedly connected through other manners, as long as the confluence block 13 is fixedly arranged on the reagent injection equipment 200. The confluence block 13 is connected with the confluence pipeline 10 and the plurality of delivery pipelines 20, so that the plurality of delivery pipelines 20 and the confluence pipeline 10 can be converged at the confluence block 13, the confluence cavity 14 can be formed in the confluence block 13, and the confluence cavity 14 is in communication with the confluence pipeline 10 and the plurality of delivery pipelines 20. In the use scenario of radiopharmaceutical injection, the reagents in the plurality of delivery pipelines 20 can flow into the confluence cavity 14 and then flow into the confluence pipeline 10. Specifically, before drug injection, physiological saline is delivered to empty the air in the pipeline, and after drug injection, physiological saline is delivered to flush the confluence pipeline 10, so that the residual drug solution in the confluence pipeline 10 is pushed into the patient's body, thereby making the reagent delivery process more stable and healthy, the drug injection amount more accurate, and the harm of toxic and radioactive reagents to the health of the staff avoided. In addition, in the drug mixing use scenario, the reagents in the plurality of delivery pipelines 20 can flow into the confluence cavity 14 for mixing and then flow into the confluence pipeline 10, so as to achieve the purpose of mixing reagents.

[0047] According to some embodiments of the present application, as shown in FIG. 5, the shielding box 301 can have a top cover 51, which is a top wall of the first shielding cavity 302. The top cover 51 is rotatably or slidably arranged on the shielding box 301 to open or close the first shielding cavity 302.

[0048] The top cover 51 is rotatably arranged on the shielding box body 301, or the top cover 51 is slidably arranged on the shielding box body 301. The application is described by taking the example of the top cover 51 being slidably arranged on the shielding box body 301. For example, the top cover 51 and the shielding box body 301 can be connected through a sliding rail, or the top cover 51 and the shielding box body 301 can be connected through a sliding buckle, but the application is not limited thereto. The top cover 51 and the shielding box body 301 can also be connected in other ways, as long as the top cover 51 is slidably arranged on the shielding box body 301. The application is described by taking the example of the top cover 51 and the shielding box body 301 being connected through a sliding rail.

[0049] By arranging the top cover 51 that can slide on the shielding box body 301, and the top cover 51 and the shielding box body 301 can be connected through a sliding rail to open or close the first shielding cavity 302, so that the user can easily open or close the first shielding cavity 302. The sliding rail connection makes the top cover 51 not need additional space when opening or closing the first shielding cavity 302, and also does not need to use complex tools or exert excessive force. Not only does it improve convenience, but the top cover 51 also makes the shielding box body 301 more compact when closing the first shielding cavity 302, facilitating the movement of the shielding box body 301.

[0050] According to some embodiments of the application, as shown in FIG. 6, the automatic drug delivery device 300 can further include a locking structure 52 arranged on the shielding box body 301, and the locking structure 52 is used to lock or unlock the top cover 51.

[0051] The locking structure 52 can be a mechanical lock, a sliding rail locking motor structure, a locking screw, a locking block, or the like. The locking structure 52 is arranged on the shielding box body 301. For example, the locking structure 52 and the shielding box body 301 can be fixedly connected through a bolt, or the locking structure 52 and the shielding box body 301 can be fixedly connected through welding, but the application is not limited thereto. The locking structure 52 and the shielding box body 301 can also be fixedly connected in other ways, as long as the locking structure 52 is arranged on the shielding box body 301. The locking structure 52 is used to lock or unlock the top cover 51. When the top cover 51 needs to be opened, the locking structure 52 can be unlocked to open the top cover 51. When the top cover 51 does not need to be opened, the locking structure 52 can be locked to close the top cover 51, so as to avoid the risk of accidental sliding and opening of the top cover 51, thereby improving the safety and reliability of the automatic drug delivery device 300.

[0052] According to some embodiments of the application, the locking structure 52 can be a mechanical locking structure 52 or an electric locking structure 52.

[0053] The locking structure 52 can be configured as a mechanical locking structure 52, for example, a mechanical lock, a locking screw, a locking block, etc. The locking structure 52 can be configured as an electric locking structure 52, for example, an electromagnetic type, an electric rotary type, an electronic induction type, etc. The mechanical locking structure 52 has stable mechanical properties and high reliability, and the structure is relatively simple, easy to maintain and maintain. The electric locking structure 52 can be integrated with the control system to realize remote control and monitoring, improve the overall automation level of the system, and can be reasonably selected according to the actual situation. As long as the locking structure 52 can be used to lock or unlock the top cover 51.

[0054] According to some embodiments of the present application, as shown in FIG. 1, the top cover 51 can have a first shielding cover 307, and the shielding box 301 is formed with an operation hole 308 communicating with the first shielding cavity 302, and the first shielding cover 307 is used to open or close the operation hole 308.

[0055] The top cover 51 can have a first shielding cover 307, for example, the first shielding cover 307 and the shielding box 301 can be fixedly connected by bolts, or the first shielding cover 307 and the shielding box 301 can be fixedly connected by clamping, and the first shielding cover 307 can be rotatably connected with the shielding box 301 through a pivot shaft, but the present application is not limited thereto. The first shielding cover 307 and the shielding box 301 can also be fixedly connected by other means, as long as the shielding box 301 has the first shielding cover 307.

[0056] The shielding box 301 can be formed with an operation hole 308 communicating with the first shielding cavity 302, and the first shielding cover 307 is used to open or close the operation hole 308. When the first shielding cover 307 is opened to open the operation hole 308, the shielding tank 303 can be placed in the first shielding cavity 302. When the first shielding cover 307 is closed to cover the operation hole 308, the first shielding cavity 302 is in a sealed state, which can play a shielding role, thereby effectively protecting the personal safety of the staff and the patient. When the first shielding cover 307 is opened to open the operation hole 308, the staff's hand can be inserted into the first shielding cavity 302 through the operation hole 308 to perform related operations, such as taking out the reagent bottle 30 in the shielding tank 303 and placing it in the placement groove 306, replacing the reagent delivery device 100, and assembling the reagent delivery device 100 on the reagent injection equipment 200 and the liquid taking equipment 304, etc. After the staff completes the operation, the first shielding cover 307 is closed to the operation hole 308.

[0057] According to some embodiments of the present application, as shown in FIG. 1, the operation hole 308 and the first shielding cover 307 can be multiple, and the multiple operation holes 308 and the multiple first shielding covers 307 correspond one by one.

[0058] The operation holes 308 and the first shielding covers 307 can be multiple, for example, the automatic drug delivery device 300 can have two, three, four, etc. operation holes 308 and first shielding covers 307, but the present application is not limited thereto, and the automatic drug delivery device 300 can also have other numbers of operation holes 308 and first shielding covers 307, as long as the operation holes 308 and the first shielding covers 307 are multiple. The multiple operation holes 308 and the multiple first shielding covers 307 are one-to-one corresponding, so that the first shielding cover 307 can be used to open or close the corresponding operation hole 308. When the first shielding cover 307 is opened to make the operation hole 308 open, the shielding tank 303 can be placed in the first shielding cavity 302, and the worker's hand can be inserted into the first shielding cavity 302 through the operation hole 308 to perform related operations. When the first shielding cover 307 is closed to cover the operation hole 308, the first shielding cavity 302 is in a sealed state, which can further play a shielding role, thereby further effectively protecting the personal safety of the worker and the patient. Moreover, by providing multiple operation holes 308, multiple hands can be inserted into the first shielding cavity 302 at the same time to complete the preparation work of injecting the reagent, which is beneficial to improve the injection efficiency.

[0059] According to some embodiments of the present application, the automatic drug delivery device 300 further comprises an activity detection device 309, which can be an activity meter. The activity detection device 309 can be used to measure the activity of the reagent before and after injection. During the early preparation work of injection, the worker can detect the activity of the corresponding reagent bottle 30 through the activity detection device 309, and record the activity value of the reagent or drug in the corresponding reagent bottle 30 before injection. After the reagent or drug in the corresponding reagent bottle 30 is injected into the patient through the reagent delivery device 100, the worker can detect the activity of the reagent delivery device 100 and the reagent bottle 30 through the activity detection device 309, and record the activity value of the reagent or drug in the reagent delivery device 100 and the reagent bottle 30 after injection. The infusion dose is recorded by recording the activity difference of the reagent or drug before and after injection. The measurement data are saved in the automatic drug delivery device 300 for subsequent diagnosis and use, and the injection dose of the reagent or drug can also be accurately grasped.

[0060] According to some embodiments of the present application, as shown in FIG. 2, the top wall of the first shielding cavity 302 can be rotatably connected with the shielding box 301, for example, the top wall (top cover 51) of the first shielding cavity 302 can be connected with the shielding box 301 through a hinge, or the top wall of the first shielding cavity 302 can be connected with the shielding box 301 through a hinge, but the present application is not limited to this, the top wall (top cover 51) of the first shielding cavity 302 can also be connected with the shielding box 301 through other ways, as long as the top wall (top cover 51) of the first shielding cavity 302 can be rotatably connected with the shielding box 301. The top wall (top cover 51) of the first shielding cavity 302 can be provided with a handle 324, which can be pulled up to open the top wall of the first shielding cavity 302, so that the maintenance personnel can conveniently overhaul the parts in the first shielding cavity 302, thereby reducing the maintenance difficulty of the automatic drug delivery device 300, and further reducing the maintenance cost of the automatic drug delivery device 300. In addition, it is also convenient to put the parts into the first shielding cavity 302, and it is also convenient to take out the parts in the first shielding cavity 302.

[0061] According to some embodiments of the present application, as shown in FIG. 2, the activity detection device 309 can be arranged in the first shielding cavity 302 or sunk and fixed in the first shielding cavity 302, and the activity detection device 309 can be used to place the reagent delivery device 100 and / or the corresponding reagent bottle 30.

[0062] Among them, the activity detection device 309 can be used to place the reagent delivery device 100, or the activity detection device 309 can be used to place the corresponding reagent bottle 30, or the activity detection device 309 can be used to place the reagent delivery device 100 and the corresponding reagent bottle 30, and the present application will be described taking the activity detection device 309 can be used to place the reagent delivery device 100 and the corresponding reagent bottle 30 as an example.

[0063] Further, in the early preparation work of injection, the staff can operate through the operation hole 308 of the first shielding cavity 302, so as to place the corresponding reagent bottle 30 into the activity detection device 309 for activity detection, and record the activity value of the reagent or medicine in the corresponding reagent bottle 30 before injection. After the reagent or medicine in the corresponding reagent bottle 30 is injected into the patient through the reagent delivery device 100, the staff can operate through the operation hole 308 of the first shielding cavity 302, so as to place the reagent delivery device 100 and the reagent bottle 30 into the activity detection device 309 for activity detection, and record the activity value of the reagent or medicine in the reagent delivery device 100 and the reagent bottle 30 after injection. The infusion dose is recorded by recording the activity difference of the reagent or medicine before and after injection, and the measurement data is saved in the automatic drug delivery device 300 for subsequent diagnosis and use, and the injection dose of the reagent or medicine can also be accurately grasped.

[0064] According to some embodiments of the present application, as shown in FIG. 2, the activity detection device 309 can be arranged in or sunk in the first shielding cavity 302. The present application takes the example of the activity detection device 309 sunk in the first shielding cavity 302 for illustration. The activity detection device 309 has an open end, and the reagent delivery device 100 and / or the corresponding reagent bottle 30 to be detected are put into the open end of the activity detection device 309. The activity detection device 309 has an open end, which is in communication with the bottom wall of the first shielding cavity 302. For example, the bottom wall of the first shielding cavity 302 and the activity detection device 309 can be connected by welding, or the bottom wall of the first shielding cavity 302 and the activity detection device 309 can be fixedly connected by bolts, but the present application is not limited thereto, and the bottom wall of the first shielding cavity 302 and the activity detection device 309 can also be connected by other ways, as long as the bottom wall of the first shielding cavity 302 and the activity detection device 309 are fixedly connected to make the activity detection device 309 in communication with the first shielding cavity 302. Thus, the staff can operate the activity detection device 309 through the operation hole 308 of the first shielding cavity 302, put the reagent delivery device 100 and / or the corresponding reagent bottle 30 into the open end of the activity detection device 309, and perform activity detection. As an embodiment of the present application, the activity detection device 309 can be used to place the reagent delivery device 100, and as another embodiment of the present application, the activity detection device 309 can be used to place the corresponding reagent bottle 30. As another embodiment of the present application, the activity detection device 309 can be used to place the corresponding reagent bottle 30 and the reagent delivery device 100.

[0065] Further, in the early preparation work before injection, the staff can operate through the operation hole 308 of the first shielding cavity 302, so as to put the corresponding reagent bottle 30 into the activity detection device 309 to perform activity detection, and record the activity value of the reagent or drug in the corresponding reagent bottle 30 before injection. After the reagent or drug in the corresponding reagent bottle 30 is injected into the patient through the reagent delivery device 100, the staff can operate through the operation hole 308 of the first shielding cavity 302, so as to put the reagent delivery device 100 and the reagent bottle 30 into the activity detection device 309 to perform activity detection, and record the activity value of the reagent or drug in the reagent delivery device 100 and the reagent bottle 30 after injection. The infusion dose is recorded by recording the activity difference of the reagent or drug before and after injection, and the measurement data are saved in the automatic drug delivery device 300 for subsequent diagnosis and use, and the injection dose of the reagent or drug can also be accurately grasped.

[0066] According to some embodiments of the present application, as shown in FIG. 6, the automatic drug delivery device 300 can further comprise a fixing frame 53, the fixing frame 53 is located in the first shielding cavity 302, the fixing frame 53 is fixedly arranged on the shielding box 301, the activity detection device 309 is used for placing the reagent delivery device 100 and / or the corresponding reagent bottle 30, the fixing frame 53 is arranged on the open end of the activity detection device 309, the fixing frame 53 is formed with a first through hole 55 corresponding to the open end of the activity detection device 309, the reagent delivery device 100 and / or the corresponding reagent bottle 30 are placed into or taken out of the activity detection device 309 through the first through hole 55. Wherein, the fixing frame 53 can be made of metal material, for example: the fixing frame 53 can be made of steel plate, iron plate and other metal materials, the fixing frame 53 is located in the first shielding cavity 302, the fixing frame 53 is fixedly arranged on the shielding box 301, for example: the fixing frame 53 and the shielding box 301 can be connected by welding, or the fixing frame 53 and the shielding box 301 can be integrally formed, but the present application is not limited thereto, the fixing frame 53 and the shielding box 301 can also be connected by other ways, as long as the fixing frame 53 is fixedly arranged on the shielding box 301. The activity detection device 309 is used for placing the reagent delivery device 100 and / or the corresponding reagent bottle 30, for example: the activity detection device 309 can be used for placing the reagent delivery device 100, or the activity detection device 309 can be used for placing the corresponding reagent bottle 30, or the activity detection device 309 can be used for placing the corresponding reagent bottle 30 and the reagent delivery device 100, and the present application takes the activity detection device 309 used for placing the corresponding reagent bottle 30 and the reagent delivery device 100 as an example for description. The first shielding cavity 302 can effectively shield external radiation and electromagnetic interference, ensure the detection environment in the activity detection device 309 to be relatively stable, help to reduce the error caused by external factors, improve the accuracy of the detection result, also can effectively shield the reagent delivery device 100 or the corresponding reagent bottle 30 in the activity detection device 309 for activity detection, reduce the radiation risk of the drug to the staff.The fixed frame 53 is provided on the open end of the activity detection device 309, and the fixed frame 53 is formed with a first through hole 55 corresponding to the open end of the activity detection device 309, the reagent conveying device 100 and / or the corresponding reagent bottle 30 is put into or taken out of the activity detection device 309 from the first through hole 55, and the fixed frame 53 can be provided with an opening and closing cover 54 for opening or closing the first through hole 55. When the opening and closing cover 54 is opened, the staff can operate the activity detection device 309 through the first through hole 55. When the corresponding reagent bottle 30 is put into the activity detection device 309 for activity detection, the opening and closing cover 54 can be closed to cover the activity detection device 309, thereby reducing the risk of potential radiation exposure, protecting the detection environment from external interference, and helping to maintain the stability of the environment in the activity detection device 309, preventing external factors (such as dust, humidity, etc.) from interfering with the detection process.

[0067] The upper end of the activity detection device 309 is open, which can facilitate the putting in and taking out of the reagent bottle 30, simplify the detection process, help to improve work efficiency, and reduce errors caused by improper operation.

[0068] According to some embodiments of the present application, as shown in FIG. 1, the automatic dosing device 300 can further include an activity display screen 310, which is provided on the shielding box 301 and located inside or outside the shielding box 301, and the activity display screen 310 is in communication connection with the activity detection device 309.

[0069] The activity display screen 310 is provided on the shielding box 301 and located inside the shielding box 301, for example, the activity display screen 310 and the shielding box 301 can be fixedly connected by bolts, or the activity display screen 310 and the shielding box 301 can be fixedly connected by clamping, but the present application is not limited thereto, the activity display screen 310 and the shielding box 301 can also be fixedly connected by other ways, as long as the activity display screen 310 is provided on the shielding box 301. The activity display screen 310 is located outside or inside the shielding box 301. When the activity display screen 310 is provided outside the shielding box 301, it is convenient for the staff to observe and record the activity display value, thereby improving the work efficiency of the staff. When the activity display screen 310 is provided inside the shielding box 301, a transparent glass window can be provided at the corresponding position of the shielding box 301 and the activity display screen 310 for displaying the activity display screen 310, which not only facilitates the staff to observe and record the activity display value, but also avoids scratching the activity display screen 310 to avoid the activity display screen 310 being blurred, and improves the appearance quality of the shielding box 301.

[0070] The activity display screen 310 is in communication connection with the activity detection device 309, for example, the activity display screen 310 and the activity detection device 309 can be in communication connection through a wire harness, or the activity display screen 310 and the activity detection device 309 can be in wireless communication connection, so that the activity display screen 310 can receive the activity value detected by the activity detection device 309 and display the activity value for the staff to record, so as to facilitate subsequent diagnosis and use.

[0071] According to some embodiments of the present application, as shown in FIG. 2, the automatic drug delivery device 300 can further include a waste shielding container 311, and the shielding box 301 is further formed with a second shielding cavity 312 in communication with the first shielding cavity 302, and the waste shielding container 311 is arranged in the second shielding cavity 312.

[0072] The automatic drug delivery device 300 can further include a waste shielding container 311, which can be used to collect the waste reagent delivery device 100 after injection, and the shielding box 301 can be further formed with a second shielding cavity 312 in communication with the first shielding cavity 302, and the waste shielding container 311 is arranged in the second shielding cavity 312, for example, the waste shielding container 311 and the shielding box 301 can be fixedly connected by bolts, or the waste shielding container 311 and the shielding box 301 can be fixedly connected by clamping, but the present application is not limited thereto, the waste shielding container 311 and the shielding box 301 can also be fixedly connected by other ways, as long as the waste shielding container 311 is arranged in the second shielding cavity 312. And the second shielding cavity 312 can be made of shielding material, for example, the second shielding cavity 312 can be made of shielding material such as lead and iron, so that the second shielding cavity 312 has shielding effect, thereby reducing the risk of radiation of the residual reagent or drug in the waste reagent delivery device 100 to the staff.

[0073] According to some embodiments of the present application, as shown in FIG. 2, the automatic drug delivery device 300 can further include a second shielding cover 313, and the shielding box 301 is formed with a communication port 314 in communication with the first shielding cavity 302 and the second shielding cavity 312, and the second shielding cover 313 is used to open or close the communication port 314.

[0074] The automatic drug delivery device 300 can further include a second shielding cover 313. The second shielding cover 313 can be fixedly connected to the shielding box 301 by bolts, or can be fixedly connected to the shielding box 301 by clamping, or can be provided in a split type, but the application is not limited thereto. The second shielding cover 313 can be fixedly connected to the shielding box 301 by other manners, as long as the automatic drug delivery device 300 includes the second shielding cover 313. The second shielding cover 313 is taken as an example which is rotatably connected to the shielding box 301 by a pivot shaft.

[0075] The shielding box 301 can be formed with a communication port 314 which communicates the first shielding cavity 302 and the second shielding cavity 312. The second shielding cover 313 is used to open or close the communication port 314. When the second shielding cover 313 is opened to make the communication port 314 open, the worker can place the waste reagent delivery device 100 into the waste shielding container 311 in the second shielding cavity 312 through the communication port 314 after the reagent delivery device 100 is removed through the operation hole 308. When the second shielding cover 313 is closed to cover the communication port 314, the second shielding cavity 312 is in a sealed state, which can play a shielding role, thereby effectively protecting the personal safety of the worker and the patient.

[0076] According to some embodiments of the present application, as shown in FIG. 2, the second shielding cavity 312 is arranged below and adjacent to the first shielding cavity 302, that is, the first shielding cavity 302 and the second shielding cavity 312 share a wall, the bottom wall of the first shielding cavity 302 is the top wall of the second shielding cavity 312, the bottom wall of the first shielding cavity 302 can be formed with a communication port 314, and the second shielding cover 313 is located in the first shielding cavity 302, that is, the second shielding cover 313 is connected with the bottom wall of the first shielding cavity 302, for example, the second shielding cover 313 and the bottom wall of the first shielding cavity 302 can be fixedly connected by bolts, or the second shielding cover 313 and the bottom wall of the first shielding cavity 302 can be fixedly connected by clamping, but the present application is not limited thereto, the second shielding cover 313 and the bottom wall of the first shielding cavity 302 can also be fixedly connected by other ways, as long as the second shielding cover 313 and the bottom wall of the first shielding cavity 302 are fixedly connected. The second shielding cover 313 can be rotatably connected with the bottom wall of the first shielding cavity 302 through a pivot shaft. In this way, the worker can open the second shielding cover 313 by inserting into the first shielding cavity 302 through the operation hole 308, and place the waste reagent conveying device 100 in the waste shielding container 311 in the second shielding cavity 312, so as to facilitate the worker to collect medical waste, thereby avoiding the risk of environmental exposure of the waste reagent conveying device 100, and effectively protecting the personal safety of the worker and the patient.

[0077] According to some embodiments of the present application, as shown in FIG. 1, the shielding box 301 can have a shielding door 315, and the second shielding cavity 312 is formed with a taking and placing opening 316, and the shielding door 315 is used to open or close the taking and placing opening 316.

[0078] Among them, the shielding box 301 can have a shielding door 315, for example, the shielding door 315 and the shielding box 301 can be connected by a shaft pin, or the shielding door 315 and the shielding box 301 can be connected by a hinge, but the present application is not limited thereto, the shielding door 315 and the shielding box 301 can also be connected by a hinge, as long as the shielding box 301 has a shielding door 315.

[0079] The second shielding cavity 312 can be formed with a taking and placing opening 316, and a shielding door 315 can be matched with the taking and placing opening 316, so that the shielding door 315 can shield the taking and placing opening 316, and the shielding door 315 is used to open or close the taking and placing opening 316. When the shielding door 315 is opened to open the taking and placing opening 316, the waste shielding container 311 in the second shielding cavity 312 can be taken out, and the medical waste such as the waste reagent conveying device 100 of the waste shielding container 311 is transferred. After the medical waste cleaning and transferring are completed, the waste shielding container 311 is placed back into the second shielding cavity 312, and the shielding door 315 is closed to shield the taking and placing opening 316, so that the second shielding cavity 312 is in a closed state, thereby effectively reducing the risk of radiation of the medical waste such as the waste reagent conveying device 100 in the second shielding cavity 312 to the staff and the patient, and further effectively protecting the safety of the staff and the patient.

[0080] According to some embodiments of the present application, as shown in FIGS. 1 and 2, the shielding box 301 can be formed with observation openings 317 corresponding to the first shielding cavity 302. The observation openings 317 can be multiple, for example, the top wall and the side wall of the first shielding cavity 302 can be formed with observation openings 317, and the observation openings 317 can be provided with shielding glass. The shielding glass can be lead glass, which can facilitate the operation and observation of the staff, thereby improving the working accuracy and efficiency of the staff, and can also ensure the shielding effect of the first shielding cavity 302, thereby effectively protecting the safety of the staff and the patient.

[0081] According to some embodiments of the present application, the automatic drug delivery device 300 further comprises a shielding tank 303, which is adapted to be placed in the first shielding cavity 302, and the shielding tank 303 is used to store the corresponding reagent bottle 30.

[0082] The shielding tank 303 can be a lead tank, so that the shielding tank 303 has shielding performance and can shield radiation. The shielding tank 303 is adapted to be placed in the first shielding cavity 302, and the shielding tank 303 is used to store the corresponding reagent bottle 30. When the corresponding reagent bottle 30 stores radioactive drugs, the first shielding cavity 302 and the shielding tank 303 can double shield radiation, thereby effectively protecting the safety of the staff and the patient.

[0083] According to some embodiments of the present application, the shielding tank 303 can be multiple, for example, there can be two, three, four, etc. number of shielding tanks 303, but the present application is not limited thereto, and there can be other numbers of shielding tanks 303, as long as the shielding tank 303 is multiple. The multiple shielding tanks 303 are all suitable to be placed in the first shielding cavity 302, and each shielding tank 303 has an reagent bottle 30 placed therein and corresponds to a patient for use. The staff can place multiple shielding tanks 303 containing reagent bottles 30 in the first shielding cavity 302 through the operation hole 308 of the first shielding cavity 302, so that the automatic drug delivery device 300 can place multiple reagent bottles 30 at the same time, thereby reducing the number of times the staff takes reagents or drugs back and forth, and thus improving the injection efficiency of the automatic drug delivery device 300.

[0084] It can be explained that the number of shielding tanks 303 can be reasonably set according to actual conditions, as long as it can meet the normal work of the automatic drug delivery device 300.

[0085] According to some embodiments of the present application, as shown in FIG. 1, the automatic drug delivery device 300 can further include a controller 318, the controller 318 is in communication connection with the reagent injection device 200, and the controller 318 is configured to control the reagent injection device 200 to work.

[0086] Among them, the automatic drug delivery device 300 can further include a controller 318, the controller 318 is in communication connection with the reagent injection device 200, for example, the controller 318 and the reagent injection device 200 can be in communication connection through a wire harness, or the controller 318 and the reagent injection device 200 are in wireless communication connection, as long as the controller 318 and the reagent injection device 200 are in communication connection. And the controller 318 is configured to control the reagent injection device 200 to work, thereby the staff can control the reagent injection device 200 to work by operating the controller 318, thereby reducing the staff's contact with the reagent bottle 30, and thus reducing the irradiation harm of the reagent to the staff. For example, the staff can control the work and working power of the drive pump 23 of the reagent injection device 200 by operating the controller 318. As an embodiment of the present application, the controller 318 can be a tablet computer, which can be operated in hand or placed on the automatic drug delivery device 300. The controller 318 can include functions such as: controlling the automatic drug delivery device 300 to self-check, run, set parameters (parameters including drug dose and flow rate), alarm; display relevant parameters, etc., thereby facilitating the automatic injection work of the automatic drug delivery device 300.

[0087] According to some embodiments of the present application, as shown in FIG. 5, the outer part of the shielding box 301 can be formed with a storage groove for placing the controller 318, which can be a tablet computer, a smart display screen, etc., so that the position of the controller 318 is more conspicuous and easy to access, facilitating the operation and control of the controller 318 by the staff, and the placement of the controller 318 in the storage groove can reduce the sliding or loss of the controller 318 during the movement of the automatic drug delivery device 300, improving the safety of the automatic drug delivery device 300.

[0088] According to some embodiments of the present application, as shown in FIG. 5, the automatic drug delivery device 300 further comprises an operation table 56, which is fixedly arranged on the shielding box 301 and located outside and on one side of the first shielding cavity 302, and the top wall of the operation table 56 is formed with a storage groove arranged obliquely along the height direction of the automatic drug delivery device 300.

[0089] The operation table 56 is fixedly arranged on the shielding box 301, for example, the operation table 56 and the shielding box 301 can be integrally formed, or the operation table 56 and the shielding box 301 can be fixedly connected by bolts, but the present application is not limited thereto, and the operation table 56 and the shielding box 301 can also be fixedly connected by other ways, as long as the operation table 56 is fixedly arranged on the shielding box 301.

[0090] The operation table 56 is located outside and on one side of the first shielding cavity 302. Specifically, the operation table 56 can be arranged on the side of the first shielding cavity 302 close to the activity display screen 310, and the top wall of the operation table 56 is formed with a storage groove arranged obliquely along the height direction of the automatic drug delivery device 300, which can be used to place the controller 318, so that the staff does not need to hold the controller 318, facilitating the operation of the controller 318 by the staff. In addition, the height of the end wall of the storage groove close to the edge of the shielding box 301 is lower than the height of the end wall of the storage groove close to the first shielding cavity 302. In this way, when the controller 318 is placed in the storage groove, the screen of the controller 318 is inclined towards the staff, so that the staff can more clearly see the information on the controller 318, and the staff can easily access the controller 318 while maintaining a comfortable posture, reducing the fatigue of the staff.

[0091] According to some embodiments of the present application, the automatic drug delivery device 300 can further comprise an anti-loss structure connected with the controller 318 and the shielding box 301.

[0092] The anti-lost structure can be configured as a chain, a hanging rope or the like. The anti-lost structure is connected with the controller 318 and the shielding box 301, so as to connect the controller 318 to the shielding box 301. During the movement of the shielding box 301, the anti-lost structure can effectively prevent the controller 318 from being damaged due to accidental falling, and can also prevent the controller 318 from falling from the shielding box 301 and being lost, thereby prolonging the service life of the controller 318 and reducing the use cost of the automatic drug delivery device 300.

[0093] According to some embodiments of the present application, as shown in FIG. 5, the automatic drug delivery device 300 further comprises an emergency stop operation key 319 and an operation table 56. The operation table 56 is fixedly arranged on the shielding box 301, and the operation table 56 is located outside the first shielding cavity 302 and on one side of the first shielding cavity 302. The top wall of the operation table 56 is provided with the emergency stop operation key 319. The emergency stop operation key 319 is configured to cut off the connection between the automatic drug delivery device 300 and the power supply.

[0094] The automatic drug delivery device 300 can further comprise an emergency stop operation key 319 and an operation table 56. The emergency stop operation key 319 is configured to cut off the connection between the automatic drug delivery device 300 and the power supply. When the reagent injection is completed or an emergency situation occurs, for example, when the controller 318 fails to control, cutting off the power supply of the reagent injection vehicle 300 through the emergency stop operation key 319 is a safety measure to ensure safety. The staff can cut off the connection between the automatic drug delivery device 300 and the power supply by triggering the emergency stop operation key 319, thereby controlling the reagent injection device 200 to stop working, thereby reducing the risk of injection failure of the automatic drug delivery device 300, and thereby improving the safety and reliability of the automatic drug delivery device 300.

[0095] The operation table 56 is fixedly arranged on the shielding box 301. For example, the operation table 56 and the shielding box 301 can be integrally formed, or the operation table 56 and the shielding box 301 can be fixedly connected by bolts, but the present application is not limited thereto. The operation table 56 and the shielding box 301 can also be fixedly connected by other means, as long as the operation table 56 is fixedly arranged on the shielding box 301.

[0096] The operation table 56 is located outside the first shielding cavity 302 and on one side of the first shielding cavity 302. The top wall of the operation table 56 is provided with the emergency stop operation key 319. In this way, the emergency stop operation key 319 and the controller 318 can be integrated at the operation table 56. The height of the operation table 56 is adapted to the height of the human body, so as to facilitate the operation of the staff, improve the convenience and efficiency of the operation, thereby helping the staff to quickly respond in an emergency, reducing the possibility of accidents, and reducing unnecessary body movement and fatigue of the staff during operation.

[0097] According to some embodiments of the present application, as shown in FIG. 5, the automatic drug delivery device 300 further comprises a power operation key 57 and an operation platform 56, the operation platform 56 is fixedly arranged on the shielding box 301, and the operation platform 56 is located outside and on one side of the first shielding cavity 302. The top wall of the operation platform 56 is provided with the power operation key 57, which is configured to control the power-on or power-off of the automatic drug delivery device 300.

[0098] The operation platform 56 is fixedly arranged on the shielding box 301, for example, the operation platform 56 and the shielding box 301 can be integrally formed, or the operation platform 56 and the shielding box 301 can be fixedly connected by bolts, but the present application is not limited thereto, and the operation platform 56 and the shielding box 301 can also be fixedly connected by other means, as long as the operation platform 56 is fixedly arranged on the shielding box 301.

[0099] The operation platform 56 is located outside and on one side of the first shielding cavity 302, and the top wall of the operation platform 56 is provided with the power operation key 57. In this way, the power operation key 57 can be integrated at the operation platform 56, and the height of the operation platform 56 is adapted to the height of the human body, so as to facilitate the operation of the staff, so that the staff can quickly control the power-on or power-off of the automatic drug delivery device 300, improve the convenience and efficiency of operation, and reduce unnecessary body movement and fatigue of the staff during operation.

[0100] According to some embodiments of the present application, as shown in FIG. 7, the automatic drug delivery device 300 can further comprise a disinfection device 58, which can be a physical disinfection device, a chemical disinfection device, etc., such as an ultraviolet disinfection lamp, a sprayer, etc. The present application takes the ultraviolet disinfection lamp as an example for description. The ultraviolet disinfection lamp uses the sterilization effect of ultraviolet rays for disinfection. The disinfection device 58 is arranged in the first shielding cavity 302, which can perform disinfection and killing treatment in the first shielding cavity 302, so as to quickly kill bacteria, viruses and other microorganisms in the first shielding cavity 302, so as to maintain a clean environment in the first shielding cavity 302, thereby providing further protection for patient safety. The disinfection device 58 is selectively turned on or turned off, which can be used for precise disinfection of specific areas or specific time, so as to ensure the disinfection effect, reduce unnecessary disinfection operation, improve disinfection efficiency, avoid excessive use leading to equipment wear and aging, prolong the service life of the equipment, reduce maintenance cost, avoid unnecessary energy waste, reduce overall energy consumption, improve energy utilization efficiency, and meet the energy saving and environmental protection concept.

[0101] According to some embodiments of the present application, as shown in FIG. 7, the disinfection device 58 is located on the side wall of the first shielding cavity 302, for example, the disinfection device 58 and the shielding box 301 can be fixedly connected by bolts, or the disinfection device 58 and the shielding box 301 can be fixedly connected by adhesion, but the present application is not limited to this, the disinfection device 58 and the shielding box 301 can also be fixedly connected by other ways, as long as the disinfection device 58 is located on the side wall of the first shielding cavity 302. By locating the disinfection device 58 on the side wall of the first shielding cavity 302, it can be ensured that the ultraviolet light can uniformly irradiate every corner in the first shielding cavity 302, avoiding the disinfection dead angle caused by uneven distribution of ultraviolet light. The fixedly installed disinfection device 58 can provide more stable and more continuous ultraviolet light, thereby enhancing the disinfection effect. In addition, since the disinfection device 58 is relatively fixed, it also reduces the problems of insufficient disinfection or over-disinfection caused by the movement of ultraviolet light, and it is easier to manage and monitor the disinfection device 58, to monitor its working state and disinfection effect in real time, thereby ensuring the smooth progress of disinfection work.

[0102] According to some embodiments of the present application, as shown in FIG. 5, the automatic drug delivery device 300 can also include a disinfection operation key 59, which is configured to cut off or conduct the connection between the disinfection device 58 and the power supply. When the worker presses the disinfection operation key 59, the disinfection operation key 59 can conduct the connection between the disinfection device 58 and the power supply, so that the disinfection device 58 can receive the power provided by the power supply and perform disinfection work. When the worker presses the disinfection operation key 59 again, the disinfection operation key 59 can cut off the connection between the disinfection device 58 and the power supply, at this time, the power supply no longer provides power to the disinfection device 58, and the disinfection device 58 stops disinfection work. Through simple key operation, the worker can conveniently control the opening and closing of the disinfection device 58 to meet different disinfection needs.

[0103] Further, when the automatic drug delivery device 300 is not working, the first shielding cavity 302 can be disinfected by the disinfection device 58, which can greatly reduce the generation of bacteria, so that the automatic drug delivery device 300 has a safe working environment, thereby effectively ensuring the safety of the patient's medication.

[0104] According to some embodiments of the present application, as shown in FIG. 5, the automatic drug delivery device 300 further includes an operation table 56, which is fixedly arranged on the shielding box 301, and the operation table 56 is located outside the first shielding cavity 302 and on one side of the first shielding cavity 302. The top wall of the operation table 56 is provided with a disinfection operation key 59.

[0105] The operation table 56 is fixedly arranged on the shielding box 301, and the operation table 56 is located outside the first shielding cavity 302 and on one side of the first shielding cavity 302. The top wall of the operation table 56 is provided with a disinfection operation key 59. In this way, the disinfection operation key 59 can be integrated on the operation table 56. The height of the operation table 56 is adapted to the height of the human body, so as to facilitate the operation of the staff, improve the convenience and efficiency of the operation, and reduce unnecessary body movement and fatigue of the staff during operation.

[0106] According to some embodiments of the present application, as shown in FIG. 5, the automatic drug delivery device 300 further comprises a table plate 60 arranged on the outer surface of the shielding box 301, and the table plate 60 is used for placing objects.

[0107] The table plate 60 is arranged on the outer surface of the shielding box 301, for example, the table plate 60 and the shielding box 301 can be fixedly connected by bolts, or the table plate 60 and the shielding box 301 can be fixedly connected by clamping, but the present application is not limited thereto. The table plate 60 and the shielding box 301 can also be fixedly connected by other means, as long as the table plate 60 is arranged on the outer surface of the shielding box 301. The table plate 60 can be used for placing objects, which facilitates the staff to quickly take and place objects, greatly improves the efficiency and convenience of the staff in work, and also provides a more comfortable and safe medical environment for patients. The size and load capacity of the table plate 60 can be customized according to actual needs, which is not limited here.

[0108] According to some embodiments of the present application, as shown in FIG. 7, the table plate 60 is movably arranged on the shielding box 301, and the table plate 60 has a first position and a second position. When the table plate 60 is located at the first position, the table plate 60 is parallel to the horizontal plane. When the table plate 60 is located at the second position, the table plate 60 is perpendicular to the horizontal plane.

[0109] The table plate 60 is movably arranged in the shielding box 301. For example, the table plate 60 and the shielding box 301 can be connected through a rotating shaft, or the table plate 60 and the shielding box 301 can be connected through a sliding rail, or the table plate 60 and the shielding box 301 can be connected through a hinge, but the application is not limited to this. The table plate 60 and the shielding box 301 can be connected through other ways as long as the table plate 60 is movably arranged in the shielding box 301. The table plate 60 is movably arranged in the shielding box 301, so that the table plate 60 can move to the first position and the second position. The table plate 60 is taken as an example of being rotatably connected with the shielding box 301 for description. The table plate 60 has the first position and the second position. When the table plate 60 is located at the first position, the table plate 60 is parallel to the horizontal plane. When the table plate 60 is located at the second position, the table plate 60 is perpendicular to the horizontal plane. The table plate 60 can rotate from the first position to the second position, and the table plate 60 can also rotate from the second position to the first position. When the table plate 60 is needed to be used to place articles, the table plate 60 can be rotated from the second position to the first position, so that the table plate 60 is parallel to the horizontal plane, and then articles can be placed on the table plate 60. When the table plate 60 is not needed to be used, the table plate 60 can be rotated from the first position to the second position, so that the table plate 60 is perpendicular to the horizontal plane, and the table plate 60 can be folded up, so as to save space or avoid the table plate 60 from knocking the patient. The use of the table plate 60 is more flexible, so as to adapt to different needs, and then the functionality of the automatic drug delivery device 300 can be improved.

[0110] According to some embodiments of the application, as shown in FIG. 7, the automatic drug delivery device 300 further comprises a support structure 61 connected between the table plate 60 and the shielding box 301. When the table plate 60 is located at the first position, the support structure 61 supports the table plate 60.

[0111] The support structure 61 is connected between the table plate 60 and the shielding box 301. For example, the support structure 61, the table plate 60 and the shielding box 301 can be connected through a pin shaft, a rotating shaft or the like, but the application is not limited to this. The support structure 61, the table plate 60 and the shielding box 301 can also be connected through other ways as long as the support structure 61 is connected between the table plate 60 and the shielding box 301. When the table plate 60 is located at the first position, the support structure 61 supports the table plate 60, so that the table plate 60 is parallel to the horizontal plane, and then articles can be placed on the table plate 60. The support structure 61 can support the table plate 60, so that the table plate 60 is stably parallel to the horizontal plane, thereby improving the stability and reliability of the table plate 60.

[0112] According to some embodiments of the present application, as shown in FIG. 7, the table board 60 has opposite first and second ends, the first end is rotatably arranged on the shielding box 301, the lower surface of the table board 60 is formed with a mounting beam 63, the mounting beam 63 is formed with a strip-shaped limiting hole 64, the strip-shaped limiting hole 64 extends along the arrangement direction of the first and second ends, and the support structure 61 includes a support rod 62, one end of the support rod 62 is rotatably connected with the shielding box 301, and the other end of the support rod 62 is assembled in the strip-shaped limiting hole 64 and is movable along the strip-shaped limiting hole 64.

[0113] Wherein, the table board 60 has opposite first and second ends, the first end is rotatably arranged on the shielding box 301, for example: the first end of the table board 60 and the shielding box 301 can be rotatably connected through a rotating shaft, or the first end of the table board 60 and the shielding box 301 can be rotatably connected through a hinge, but the present application is not limited thereto, the first end of the table board 60 and the shielding box 301 can also be connected through other ways, as long as the first end of the table board 60 is rotatably arranged on the shielding box 301.

[0114] The lower surface of the table board 60 is formed with a mounting beam 63, for example: the table board 60 and the mounting beam 63 can be fixedly connected through welding, or the table board 60 and the mounting beam 63 can be fixedly connected through bolts, but the present application is not limited thereto, the table board 60 and the mounting beam 63 can also be fixedly connected through other ways, as long as the lower surface of the table board 60 is formed with the mounting beam 63.

[0115] The mounting beam 63 can be formed with a strip-shaped limiting hole 64, the strip-shaped limiting hole 64 extends along the arrangement direction of the first and second ends, the support structure 61 includes a support rod 62, one end of the support rod 62 is rotatably connected with the shielding box 301, for example: the support rod 62 and the shielding box 301 can be rotatably connected through a rotating shaft, or the support rod 62 and the shielding box 301 can be rotatably connected through a hinge, but the present application is not limited thereto, the support rod 62 and the shielding box 301 can also be rotatably connected through other ways, as long as one end of the support rod 62 is rotatably connected with the shielding box 301. The other end of the support rod 62 is assembled in the strip-shaped limiting hole 64 and is movable along the strip-shaped limiting hole 64, for example: the other end of the support rod 62 can be connected with a pin shaft, the pin shaft is arranged in the strip-shaped limiting hole 64, and the pin shaft can move in the strip-shaped limiting hole 64, or the other end of the support rod 62 can be designed as a sliding head with a smooth surface, the sliding head is directly inserted into the strip-shaped limiting hole 64, and the sliding head can move in the strip-shaped limiting hole 64, or the other end of the support rod 62 can be installed with a roller, the roller is assembled in the strip-shaped limiting hole 64, and the roller can rollingly move in the strip-shaped limiting hole 64, but the present application is not limited thereto, as long as the other end of the support rod 62 is assembled in the strip-shaped limiting hole 64 and is movable along the strip-shaped limiting hole 64.

[0116] Thus, by the one end of the support rod 62 being rotatably connected with the shielding box body 301 and the other end of the support rod 62 being movable along the strip-shaped limiting hole 64, the other end of the support rod 62 can conveniently prop up the table plate 60 to the first position parallel to the horizontal plane, and then the relative position of the support rod 62 and the mounting beam 63 is fixed, so that the table plate 60 can be reliably kept at the first position, and then the articles can be placed on the table plate 60.

[0117] In another embodiment, as shown in FIGS. 8 and 9, the support structure 61 can be a rotating shaft structure, the support structure 61 is connected between the table plate 60 and the shielding box body 301, when the table plate 60 is at the first position, the support structure 61 supports the table plate 60, so that the table plate 60 is parallel to the horizontal plane, and then the articles can be placed on the table plate 60, and the support structure 61 can support the table plate 60, so that the table plate 60 is stably parallel to the horizontal plane, thereby improving the stability and reliability of the table plate 60. The support structure 61, the table plate 60 and the shielding box body 301 can also be connected in other ways, as long as the support structure 61 is connected between the table plate 60 and the shielding box body 301. When the table plate 60 is at the first position, the support structure 61 supports the table plate 60, so that the table plate 60 is parallel to the horizontal plane, and then the articles can be placed on the table plate 60, and the support structure 61 can support the table plate 60, so that the table plate 60 is stably parallel to the horizontal plane, thereby improving the stability and reliability of the table plate 60. When the table plate 60 is rotated to the second position perpendicular to the horizontal plane, the support structure 61 does not need to generate a supporting force on the table plate 60, and the table plate 60 is retracted to save space or avoid the table plate 60 from knocking the patient, so that the use of the table plate 60 is more flexible to adapt to different needs, thereby further improving the functionality of the automatic drug delivery device 300.

[0118] According to some embodiments of the present application, as shown in FIG. 7, the side wall of the first shielding cavity 302 is formed with a second through hole 65 communicating with the first shielding cavity 302, the second through hole 65 can be arranged on the side wall of the first shielding cavity 302 close to the table plate 60, and the reagent injection assembly 500 is arranged through the second through hole 65, so that the reagent injection assembly 500 can pass through the second through hole 65 to be connected with the patient, thereby realizing the injection work on the patient, and such arrangement can also facilitate the maintenance and replacement of the reagent injection assembly 500, and can also reduce the risk of the reagent injection assembly 500 being blocked, thereby reducing the injection cost and improving the reliability of the automatic drug delivery device 300. It should be noted that the reagent delivery device 100 of the reagent injection assembly 500 is arranged through the second through hole 65.

[0119] As an example of the present application, as shown in Figure 6, the shielding box 301 can also be provided with a saline bag 66. The saline bag 66 can be hung on the shielding box 301 by a hanging rod, or the saline bag 66 can also be directly hung on the side wall of the shielding box 301. The saline bag 66 stores physiological saline, so that the staff can quickly take it when needed, providing timely liquid supplement for the patient. The convenient use of the saline bag 66 reduces the time of the staff to find and prepare the saline bag 66, thereby improving the efficiency of first aid and further ensuring the safety of the patient.

[0120] According to some embodiments of the present application, as shown in Figure 1, the shielding box 301 can be connected with a caster 320, for example: the caster 320 and the shielding box 301 can be connected by a rotating shaft, or the caster 320 and the shielding box 301 can be connected by a latch, but the present application is not limited to this, the caster 320 and the shielding box 301 can also be connected by other ways, as long as the shielding box 301 is connected with the caster 320. In this way, the movement of the shielding box 301 can be facilitated, thereby reducing the time of moving the automatic drug delivery device 300 to the front of the patient's bed, and further improving the injection efficiency of the automatic drug delivery device 300; also reducing the number of patient movements, facilitating the patient to inject.

[0121] According to some embodiments of the present application, as shown in Figure 1, the shielding box 301 can be provided with a handle 321, for example: the handle 321 and the shielding box 301 can be fixedly connected by welding, or the handle 321 and the shielding box 301 can be fixedly connected by bolts, but the present application is not limited to this, the handle 321 and the shielding box 301 can also be fixedly connected by other ways, as long as the shielding box 301 is provided with the handle 321. The staff can push and pull the shielding box 301 through the handle 321, which is conducive to the staff to control the moving track of the shielding box 301, thereby reducing the risk of the shielding box 301 being bumped and collided.

[0122] According to some embodiments of the present application, as shown in FIG. 5, the handle 321 can include a fixed section, a connecting section and a holding section, the connecting section is connected between the fixed section and the holding section, the fixed section can be two, which is used to be fixedly connected with the automatic drug delivery device 300, the holding section can be two, which is used for the staff to hold with both hands, the holding section of the handle 321 can be columnar, which can better fit the hand profile of the staff and provide a comfortable holding experience, the connecting section can include a connecting section body, two first sub-connecting sections, the connecting section body can be configured as a "U" shaped structure, the corresponding first sub-connecting section is connected between the connecting section body and the corresponding holding section, and an included angle is formed between the corresponding first sub-connecting section and the connecting section body and the corresponding holding section, the size of the included angle can be reasonably set according to the principle of ergonomics, which is convenient for the staff to adjust the arm and wrist angle according to the needs, can enhance the staff's control ability of the automatic drug delivery device 300, so that the moving process of the automatic drug delivery device 300 is more safe and efficient, and the holding section of the handle 321 can be covered with anti-slip materials such as rubber, silicone and the like to increase the stability and safety of the staff holding the handle 321.

[0123] In addition, the handle 321 can be arranged on the side wall of the shielding box body 301 close to the operation table 56, so that the staff can monitor and control the controller 318 on the operation table 56 at any time during the process of moving the shielding box body 301 through the handle 321, thereby reducing the risk of accidents and improving the safety of the automatic drug delivery device 300.

[0124] According to some embodiments of the present application, as shown in FIG. 9, the handle 321 can be designed as a "U" shape, the handle 321 is arranged around the circumference of the automatic drug delivery device 300, the handle 321 includes a first section, a second section and a third section, the second section is connected between the first section and the third section, the first section and the third section are parallel and spaced apart, and the first section and the third section are respectively fixedly connected with the two side walls of the automatic drug delivery device 300, the second section is parallel and spaced apart from the side wall of the automatic drug delivery device 300, so that the staff can hold the second section of the handle 321 to push the automatic drug delivery device 300. Such arrangement not only conforms to the principle of ergonomics, but also enables the user to hold in the most natural way, reduces hand fatigue and discomfort, and also makes the handle 321 more visually simple, while occupying less space, which is suitable for occasions with limited space and can also improve the overall design aesthetics of the automatic drug delivery device 300.

[0125] According to some embodiments of the present application, as shown in FIG. 2, the shielding box 301 can have a mounting cavity 322, which can be a shielding cavity, or can not be configured as a shielding cavity. The mounting cavity 322 can be located below the first shielding cavity 302 and the second shielding cavity 312. A power supply and electrical components can be arranged in the mounting cavity 322. The electrical components can realize the connection, control, protection and other functions of the circuit of the automatic drug delivery device 300. The power supply can provide power for the entire automatic drug delivery device 300. The power supply, the electrical components and the controller 318 are connected. Through the cooperation of the power supply, the electrical components and the controller 318, the controller 318 can control the cooperation of various components of the automatic drug delivery device 300. Only the input of the patient treatment plan can realize automatic injection, simplify the operation steps of injection, and greatly reduce the contact between the staff and the reagent during the injection process, thereby reducing the radiation hazards of the reagent to the staff, and effectively protecting the personal safety of the staff and the patient.

[0126] According to some embodiments of the present application, as shown in FIG. 2, the outside of the shielding box 301 can also be provided with a storage groove 323, which can be used to place the staff's notebook, controller 318 (tablet computer) and other objects, and facilitate the staff to record the working steps. The outside of the shielding box 301 can also be provided with a hook 325, which can be used to hang some operating tools or device power lines that the staff often uses, so as to avoid the staff to take the tools back and forth, and thereby improve the work efficiency.

[0127] According to some embodiments of the present application, as shown in FIG. 3, a plurality of fixing seats 203 are fixed on the outer surface of the reagent injection device 200, and the plurality of fixing seats 203 are respectively used for mounting the manifold pipe 10 and the plurality of delivery pipes 20.

[0128] The outer surface of the reagent injection device 200 can be fixed with a plurality of fixing seats 203, for example, the outer surface of the reagent injection device 200 can be fixed with two, three, four or the like number of fixing seats 203, but the application is not limited to this, the outer surface of the reagent injection device 200 can also be fixed with other number of fixing seats 203, as long as the outer surface of the reagent injection device 200 is fixed with a plurality of fixing seats 203. The plurality of fixing seats 203 are respectively used to install the manifold pipeline 10 and the plurality of conveying pipelines 20, the fixing seat 203 can be formed with a clamping interface, the manifold pipeline 10 can be clamped in the clamping interface of the corresponding fixing seat 203, the conveying pipeline 20 can be clamped in the clamping interface of the corresponding fixing seat 203, the manifold pipeline 10 can also be bonded to the corresponding fixing seat 203, and the conveying pipeline 20 can also be bonded to the corresponding fixing seat 203. In this way, the extension path of the manifold pipeline 10 and the conveying pipeline 20 can be regularized, so as to reduce the risk of movement and collision of the manifold pipeline 10 and the conveying pipeline 20, and also reduce the risk of mutual entanglement of the manifold pipeline 10 and the conveying pipeline 20, and further reduce the risk of entanglement of the manifold pipeline 10 and the conveying pipeline 20 with other components on the surface of the shell 202, thereby facilitating to improve the safety and reliability of the manifold pipeline 10 and the conveying pipeline 20 for conveying reagents.

[0129] The reagent delivery device 100 of the application can be used in a radioactive drug injection scene, or can also be used in other reagent mixing scenes, for example, can be used in a drug mixing use scene, and can be communicated with a reagent container to mix drugs for use.

[0130] According to some embodiments of the application, as shown in FIG. 3, at least one of the manifold pipeline 10 and the plurality of conveying pipelines 20 is provided with a bubble detection piece 41, and the bubble detection piece 41 is fixed to the reagent injection device 200.

[0131] At least one of the manifold pipeline 10 and the plurality of conveying pipelines 20 is provided with a bubble detection piece 41, for example, the manifold pipeline 10 can be provided with a bubble detection piece 41, or one of the conveying pipelines 20 can be provided with a bubble detection piece 41, but the application is not limited to this, the manifold pipeline 10 and one of the conveying pipelines 20 can also be provided with a bubble detection piece 41, as long as at least one of the manifold pipeline 10 and the plurality of conveying pipelines 20 is provided with a bubble detection piece 41. As an embodiment of the application, the manifold pipeline 10 and the plurality of conveying pipelines 20 are both provided with a bubble detection piece 41, and the bubble detection piece 41 can be a bubble sensor. In this way, whether there is a bubble in the manifold pipeline 10 and the plurality of conveying pipelines 20 can be detected, so that the staff can timely remove the bubble, thereby effectively avoiding the bubble from entering the patient's body, thereby facilitating to protect the safety of the patient.

[0132] The bubble detection member 41 can be fixed to the reagent injection device 200. For example, the bubble detection member 41 and the reagent injection device 200 can be connected by clamping, or the bubble detection member 41 and the reagent injection device 200 can be connected by bonding, but the application is not limited to this. The bubble detection member 41 and the reagent injection device 200 can also be connected in other ways, as long as the bubble detection member 41 is fixed to the reagent injection device 200. In this way, the bubble detection member 41 is fixed to the reagent injection device 200, which can reduce the risk of the bubble detection member 41 moving around and affecting the detection effect, thereby improving the safety and reliability of the bubble detection member 41.

[0133] According to some embodiments of the application, as shown in FIG. 3, the manifold pipe 10 is provided with a flow detection member 40, and the flow detection member 40 is fixed to the reagent injection device 200.

[0134] The manifold pipe 10 can be provided with a flow detection member 40, which can detect the flow of the drug in the manifold pipe 10, accurately record real-time measurement data, facilitate subsequent diagnosis, and further improve the safety of the reagent delivery device 100 in cooperation with the bubble detection member 41. In this way, the safety and reliability of the patient can be further improved. The flow detection member 40 is fixed to the reagent injection device 200. For example, the flow detection member 40 and the reagent injection device 200 can be connected by clamping, or the flow detection member 40 and the reagent injection device 200 can be connected by bonding, but the application is not limited to this. The flow detection member 40 and the reagent injection device 200 can also be connected in other ways, as long as the flow detection member 40 is fixed to the reagent injection device 200. In this way, the flow detection member 40 is fixed to the reagent injection device 200, which can reduce the risk of the flow detection member 40 moving around and affecting the detection effect, thereby improving the safety and reliability of the flow detection member 40.

[0135] According to some embodiments of the application, as shown in FIG. 3, the manifold pipe 10 is provided with an air filter 43.

[0136] The manifold pipe 10 can be provided with an air filter 43, which can filter microorganisms, particulate matter, and bubbles in the drug solution during infusion, thereby avoiding infection, allergy, and other symptoms in patients, effectively ensuring the safety of patients, and improving the safety and reliability of the reagent injection device 200.

[0137] The air filter 43 and the reagent converging pipeline 10 can be integrated, and the converging pipeline 10 is fixedly connected with the reagent injection device 200, so that the risk of air filter 43 movement can be reduced to avoid the air filter 43 from moving randomly and affecting the detection effect, and thus the safety and reliability of the air filter 43 can be improved.

[0138] According to some embodiments of the present application, as shown in FIGS. 9 and 10, the automatic dosing device 300 can further include a bracket seat 68 fixedly arranged in the first shielding cavity 302, and an upper surface of the bracket seat 68 is at least partially an installation inclined surface 681, and the air filter 43 is installed on the installation inclined surface 681.

[0139] The bracket seat 68 is fixedly arranged in the first shielding cavity 302 for installing the air filter 43, and an upper surface of the bracket seat 68 is at least partially an installation inclined surface 681, for example, one-half, one-third or other proportion of the upper surface of the bracket seat 68 is the installation inclined surface 681, or the entire upper surface of the bracket seat 68 is the installation inclined surface 681, as long as the upper surface of the bracket seat 68 is at least partially the installation inclined surface 681. The air filter 43 is installed on the installation inclined surface 681, which not only enables the air filter 43 to be properly installed in a limited space and avoids space waste, but also helps to improve the airflow distribution in the air filter 43, enables air to pass through the air filter 43 more uniformly, helps to improve the filtering efficiency of the air filter 43, and reduces the accumulation of dust and pollutants.

[0140] According to some embodiments of the present application, as shown in FIG. 9, the automatic dosing device 300 can further include a fixing frame 53 located in the first shielding cavity 302 and fixedly arranged in the shielding box 301, and the bracket seat 68 is fixedly arranged in the fixing frame 53.

[0141] The fixing frame 53 is located in the first shielding cavity 302 and fixedly arranged in the shielding box 301, for example, the fixing frame 53 and the shielding box 301 can be connected by welding, or the fixing frame 53 and the shielding box 301 can be integrally formed, but the present application is not limited thereto, and the fixing frame 53 and the shielding box 301 can also be connected by other means, as long as the fixing frame 53 is fixedly arranged in the shielding box 301. The bracket seat 68 is fixedly arranged in the fixing frame 53, for example, the bracket seat 68 and the fixing frame 53 can be fixedly connected by welding, or the bracket seat 68 and the fixing frame 53 can be integrally formed, but the present application is not limited thereto, and the bracket seat 68 and the fixing frame 53 can also be fixedly connected by other means, as long as the bracket seat 68 is fixedly arranged in the fixing frame 53.

[0142] Thus, the fixing frame 53 is located in the first shielding cavity 302 and fixed to the shielding box 301, can serve as a support structure of the shielding box 301, can effectively disperse and bear the force received by the shielding box 301, and reduce the risk of shaking or tilting of the shielding box 301 during use. The bracket seat 68 is fixed to the fixing frame 53 and can be used to mount the air filter 43. The bracket seat 68 is closely connected to the shielding box 301 through the fixing frame 53, ensuring stable installation of the air filter 43, so as to ensure stable operation of the air filter 43, thereby improving the safety and reliability of the automatic drug delivery device 300.

[0143] According to some embodiments of the present application, as shown in FIG. 9, the surface of the fixing frame 53 can be fixed with a plurality of fixing seats 203, for example, the surface of the fixing frame 53 can be fixed with two, three, four or the like number of fixing seats 203, but the present application is not limited thereto, and the surface of the fixing frame 53 can also be fixed with other number of fixing seats 203, as long as the surface of the fixing frame 53 is fixed with a plurality of fixing seats 203. The plurality of fixing seats 203 are respectively used to mount the manifold pipe 10 and the plurality of delivery pipes 20. The fixing seat 203 can be formed with a clamping port, the manifold pipe 10 can be clamped in the clamping port of the corresponding fixing seat 203, the delivery pipe 20 can be clamped in the clamping port of the corresponding fixing seat 203, or the manifold pipe 10 can be adhered to the corresponding fixing seat 203, and the delivery pipe 20 can be adhered to the corresponding fixing seat 203. In this way, the extension path of the manifold pipe 10 and the delivery pipe 20 can be regularized, so as to reduce the risk of movement and collision of the manifold pipe 10 and the delivery pipe 20, and also reduce the risk of mutual entanglement of the manifold pipe 10 and the delivery pipe 20, and further reduce the risk of entanglement of the manifold pipe 10 and the delivery pipe 20 with other components on the surface of the housing 202, thereby facilitating improvement of the safety and reliability of the delivery of the reagent by the manifold pipe 10 and the delivery pipe 20.

[0144] According to some embodiments of the present application, as shown in FIG. 9, the surface of the fixing frame 53 can be fixed with a plurality of driving pumps 23, and each delivery pipe 20 cooperates with a corresponding driving pump 23 to make the reagent in the corresponding reagent bottle 30 flow into the manifold pipe 10. The manifold pipe 10 is adapted to communicate with the infusion member, thereby enabling the infusion member to deliver the medicine or liquid into the patient's body.

[0145] According to some embodiments of the present application, at least one of the manifold pipe 10 and the plurality of delivery pipes 20 is configured as a hose, for example, the manifold pipe 10 can be configured as a hose, or the plurality of delivery pipes 20 can all be configured as hoses, but the present application is not limited to this, the manifold pipe 10 and the plurality of delivery pipes 20 can all be configured as hoses, as long as at least one of the manifold pipe 10 and the plurality of delivery pipes 20 is configured as a hose. As an embodiment of the present application, the manifold pipe 10 and the plurality of delivery pipes 20 can all be configured as hoses, the hose is made of non-toxic material, which can ensure that the patient is not harmed during infusion, the hose material has a certain elasticity, which can adapt to the pressure change during infusion, and can withstand the flow pressure of the infusion liquid, the hose has softness, which can pass through curves and bends, facilitating the operation and adjustment during infusion, and also facilitating the connection of the delivery pipe 20 with the reagent bottle 30, the connection of the manifold pipe 10 with the infusion device, so as to deliver the reagent to the patient's body. Therefore, configuring the manifold pipe 10 and the plurality of delivery pipes 20 as hoses can effectively ensure the safety and reliability of the infusion process, thereby facilitating the safety of the patient.

[0146] According to some embodiments of the present application, as shown in FIG. 3, the reagent injection assembly 500 can further include a liquid taking device 304, the liquid taking device 304 and the reagent delivery device 100 are both arranged in the first shielding cavity 302, and the liquid taking device 304 is used to place the corresponding reagent bottle 30. The liquid taking device 304 cooperates with the reagent delivery device 100 to drive the reagent delivery device 100 to insert or pull out the corresponding reagent bottle 30.

[0147] Among them, the liquid taking device 304 and the reagent delivery device 100 are both arranged in the first shielding cavity 302, for example, the liquid taking device 304, the reagent delivery device 100 and the movable box body 301 can all be connected by clamping, or the liquid taking device 304, the reagent delivery device 100 and the movable box body 301 can all be connected by bolts, but the present application is not limited to this, the liquid taking device 304, the reagent delivery device 100 and the movable box body 301 can also be connected by other ways, as long as the liquid taking device 304 and the reagent delivery device 100 are both arranged in the first shielding cavity 302. In this way, the first shielding cavity 302 can shield the liquid taking device 304 and the reagent delivery device 100, thereby reducing the radiation hazard of the reagent or drug delivered in the reagent delivery device 100 to the staff, and the first shielding cavity 302 can also cover the liquid taking device 304 and the reagent delivery device 100 to play a protective role, thereby reducing the risk of collision and scratching of the liquid taking device 304 and the reagent delivery device 100 by external objects, and thereby improving the service life of the movable injection trolley 300.

[0148] The liquid taking device 304 is used for placing the corresponding reagent bottle 30, and the liquid taking device 304 cooperates with the reagent conveying device 100 to drive the reagent conveying device 100 to be inserted into or pulled out of the corresponding reagent bottle 30. When the liquid taking device 304 cooperates with the reagent conveying device 100 to drive the reagent conveying device 100 to be inserted into the corresponding reagent bottle 30, the reagent conveying device 100 can take the reagent in the corresponding reagent bottle 30. When the reagent in the corresponding reagent bottle 30 is taken out or the reagent conveying device 100 needs to be replaced, the liquid taking device 304 cooperates with the reagent conveying device 100 to drive the reagent conveying device 100 to be pulled out of the corresponding reagent bottle 30, and then the corresponding reagent bottle 30 or the reagent conveying device 100 can be replaced, so as to avoid that the staff manually connects the reagent conveying device 100 with the corresponding reagent bottle 30, and then the irradiation harm of the reagent in the reagent bottle 30 to the staff can be reduced.

[0149] According to some embodiments of the present application, as shown in FIG. 3, the reagent conveying device 100 can have a needle 42, the liquid taking device 304 has a moving part 305 and a placing groove 306, the moving part 305 and the placing groove 306 are opposite and spaced apart, the placing groove 306 is used for storing the corresponding reagent bottle 30, and the needle 42 is detachably assembled in the moving part 305. The moving part 305 is moved towards or away from the placing groove 306 to drive the needle 42 to be inserted into or pulled out of the corresponding reagent bottle 30.

[0150] The reagent delivery device 100 can have a needle 42, the needle 42 is inserted into the corresponding reagent bottle 30, the reagent delivery device 100 and the reagent bottle 30 can be communicated, so that the medicine in the reagent bottle 30 can be taken. The liquid taking device 304 can have a moving part 305 and a placing groove 306, the moving part 305 and the placing groove 306 are opposite and spaced apart, the placing groove 306 is used to store the corresponding reagent bottle 30, the needle 42 is detachably assembled in the moving part 305, for example, the needle 42 and the moving part 305 can be assembled by clamping, or the needle 42 and the moving part 305 can be assembled by inserting, but the application is not limited to this, the needle 42 and the moving part 305 can also be assembled by other ways, as long as the needle 42 is detachably assembled in the moving part 305. The liquid taking device 304 can have a driving part, the driving part can be a driving motor, the driving part is in communication connection with the controller 318, the driving part is controlled by the controller 318 to drive the moving part 305 to move towards or away from the placing groove 306, so as to drive the needle 42 to be inserted into or pulled out of the corresponding reagent bottle 30. When the liquid taking device 304 cooperates with the reagent delivery device 100 to drive the needle 42 to be inserted into the corresponding reagent bottle 30, the reagent delivery device 100 can take the reagent in the corresponding reagent bottle 30. When the reagent in the corresponding reagent bottle 30 is taken out or the reagent delivery device 100 needs to be replaced, the liquid taking device 304 cooperates with the reagent delivery device 100 to drive the needle 42 to be pulled out of the corresponding reagent bottle 30, so that the reagent bottle 30 and the reagent delivery device 100 can be replaced, so that the automatic drug delivery device 300 can inject different medicines for different patients, or only the reagent delivery device 100 is replaced, so that the automatic drug delivery device 300 can inject the same medicine for different patients, so as to reduce the number of times of taking medicine by the staff, and to improve the injection efficiency of the automatic drug delivery device 300.

[0151] According to some embodiments of the application, as shown in FIG. 9, the controller 318 is in communication connection with the liquid taking device 304, and the controller 318 is configured to control the liquid taking device 304 to work.

[0152] The controller 318 and the liquid taking device 304 can be in communication connection through a wire harness, or the controller 318 and the liquid taking device 304 are in wireless communication connection, as long as the controller 318 and the liquid taking device 304 are in communication connection. The controller 318 is configured to control the liquid taking device 304 to work, and the controller 318 is configured to control the reagent injection device 200 to work.

[0153] Thus, the operator can control the liquid taking device 304 and the reagent injection device 200 by operating the controller 318, so as to reduce the contact between the operator and the reagent bottle 30, and further reduce the radiation hazard of the reagent to the operator. For example, the operator can control the liquid taking device 304 to control the insertion or extraction of the needle 42 into or out of the reagent bottle 30 by operating the controller 318, and the operator can control the operation and working power of the driving pump 23 of the reagent injection device 200 by operating the controller 318.

[0154] According to some embodiments of the present application, as shown in FIG. 9, the automatic dosing device 300 further comprises a fixing frame 53, the fixing frame 53 is located in the first shielding cavity 302 and fixed to the shielding box 301, and part of at least one of the liquid taking device 304, the reagent injection device 200 and the reagent conveying device 100 is fixedly assembled to the fixing frame 53.

[0155] The fixing frame 53 is located in the first shielding cavity 302 and fixed to the shielding box 301, for example, the fixing frame 53 and the shielding box 301 can be connected by welding, or the fixing frame 53 and the shielding box 301 can be integrally formed, but the present application is not limited thereto, and the fixing frame 53 and the shielding box 301 can also be connected by other ways, as long as the fixing frame 53 is fixed to the shielding box 301.

[0156] Part of at least one of the liquid taking device 304, the reagent injection device 200 and the reagent conveying device 100 is fixedly assembled to the fixing frame 53, for example, part of the liquid taking device 304 is fixedly assembled to the fixing frame 53, or part of the reagent injection device 200 is fixedly assembled to the fixing frame 53, or part of the reagent conveying device 100 is fixedly assembled to the fixing frame 53, or part of the liquid taking device 304, the reagent injection device 200 and the reagent conveying device 100 is fixedly assembled to the fixing frame 53, or part of two of the liquid taking device 304, the reagent injection device 200 and the reagent conveying device 100 is fixedly assembled to the fixing frame 53.

[0157] The liquid taking device 304, the reagent injection device 200 and the reagent conveying device 100 are all partially fixedly assembled on the fixing frame 53, so that the fixing frame 53 can fix and support the liquid taking device 304, the reagent injection device 200 and the reagent conveying device 100, effectively reduce the displacement or shaking of the liquid taking device 304, the reagent injection device 200 and the reagent conveying device 100 due to vibration, impact or other external factors during the operation of the automatic dosing device 300, and ensure the normal operation and precision of the automatic dosing device 300. The design of the fixing frame 53 allows reasonable planning of the layout of the liquid taking device 304, the reagent injection device 200 and the reagent conveying device 100. Through accurate calculation and adjustment, the liquid taking device 304, the reagent injection device 200 and the reagent conveying device 100 can be installed at the best position to achieve the best work flow and efficiency, which not only can reduce the interference and conflict between devices, but also can improve the comfort and work efficiency of the staff.

[0158] In addition, the fixing frame 52 is assembled with the liquid taking device 304, and the structural member of the liquid taking device 304 is assembled on the fixing frame 52, which can optimize the shell of the liquid taking device 304, for example, the volume of the liquid taking device 304 can be reduced, or the shell of the liquid taking device 304 can be omitted. The fixing frame 52 is assembled with the reagent injection device 200, and the structural member of the reagent injection device 200 is assembled on the fixing frame 52, for example, the driving pump 23 (in this embodiment, specifically a peristaltic pump) can be directly fixed and installed on the fixing frame 52, and the shell of the reagent injection device 200 can be omitted. The fixing frame 52 is assembled with the reagent conveying device 100, and the structural member of the reagent conveying device 100 is assembled on the fixing frame 52, which can omit the shell of the reagent conveying device 100, is conducive to simplifying the structure of the automatic dosing device 300, and is also conducive to reducing the manufacturing cost of the automatic dosing device 300.

[0159] According to some embodiments of the present application, as shown in FIG. 8, the automatic dosing device 300 can further include an alarm device 69 for issuing alarm information.

[0160] The alarm device 69 can be configured as a visual alarm, an audible alarm, etc. The application takes the LED indicator and the buzzer as an example to illustrate that the alarm device 69 can emit a red or other eye-catching color when alarming, and emit a loud sound, so as to ensure that the alarm device 69 can arouse the vigilance of the staff. The alarm device 69 can be configured to send an alarm when the shielding cavity 302 is mistakenly opened. Specifically, when the automatic drug delivery device 300 is in the injection state, the alarm device 69 is configured to send an alarm when the shielding cavity 302 is mistakenly opened, so that the staff can immediately close the shielding cavity 302 when the shielding cavity 302 is mistakenly opened, thereby preventing the radioactive drug in the shielding cavity 302 from being exposed to the patient and the staff, reducing the radiation risk, and improving the safety of the automatic drug delivery device 300 when injecting the drug into the patient.

[0161] In the description of the present specification, the description of the terms "one embodiment", "some embodiments", "exemplary embodiment", "example", "specific example", or "some examples" means that the specific features, structures, materials or characteristics described in connection with the embodiment or example are included in at least one embodiment or example of the present application. In the present specification, the exemplary description of the above terms does not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described can be combined in any one or more embodiments or examples in a suitable manner.

[0162] Although the embodiments of the present application have been shown and described, those skilled in the art can understand that various changes, modifications, replacements and variations can be made to the embodiments without departing from the principles and purposes of the present application, and the scope of the present application is defined by the claims and their equivalents.

Claims

1. An automatic drug delivery device, wherein, The application relates to a shielding box body, a reagent injection assembly, and a locking structure. The shielding box body is formed with a first shielding cavity. The reagent injection assembly is arranged in the first shielding cavity, and is adapted to be connected with a reagent bottle and a transfusion member.

2. The automatic dosing device according to claim 1, wherein, The transfusion member is a retention needle or an intravenous transfusion needle.

3. The automatic dosing device according to claim 1 or 2, wherein, The reagent injection assembly comprises a reagent conveying device and a reagent injection device.

4. The automatic dosing device according to any one of claims 1 to 3, wherein, The reagent conveying device is adapted to be connected with the reagent bottle and the transfusion member. The reagent injection device is arranged in the first shielding cavity and cooperates with the reagent conveying device to drive the reagent in the reagent bottle to flow along the reagent conveying device. The reagent injection device is provided with a plurality of driving pumps.

5. The automatic dosing device according to claim 4, wherein, The reagent conveying device comprises a plurality of conveying pipelines and a converging pipeline.

6. The automatic dosing device according to claim 5, wherein, The converging pipeline is connected with the plurality of conveying pipelines.

7. The automatic dosing device according to any one of claims 1-6, wherein, The converging pipeline is adapted to be connected with the transfusion member.

8. The automatic dosing device according to claim 7, wherein The reagent conveying device further comprises a converging block. The converging block is fixedly arranged in the reagent injection device.

9. The automatic dosing device according to claim 8, wherein, The shielding box body is provided with a top cover.

10. The automatic dosing device according to any one of claims 7-9, wherein, The top cover is a top wall of the first shielding cavity.

11. The automatic dosing device according to claim 10, wherein, The top cover is rotatably or slidably arranged in the shielding box body to open or close the first shielding cavity.

12. The automatic dosing device according to any one of claims 4-6, wherein, The locking structure is arranged in the shielding box body. The locking structure is used to lock or unlock the top cover.

13. The automatic dosing device according to claim 12, wherein, The locking structure is configured as a mechanical locking structure or an electric locking structure.

14. The automatic dosing device according to claim 12 or 13, wherein The top cover is provided with a first shielding cover body. The shielding box body is formed with operation holes communicating with the first shielding cavity. The operation holes and the first shielding cover bodies are one-to-one corresponding. The activity detection device is used to measure the activity of the reagent before and after reagent injection. The activity detection device is arranged in or sunkenly arranged in the first shielding cavity. The activity detection device is used to place the reagent conveying device and / or the reagent bottle. A fixing frame is located in the first shielding cavity, the fixing frame is fixed to the shielding box, the activity detection device is used for placing the reagent delivery device and / or the corresponding reagent bottle, the fixing frame covers the open end of the activity detection device, the fixing frame is formed with a first through hole corresponding to the open end of the activity detection device, and the reagent delivery device and / or the corresponding reagent bottle are put into or taken out of the activity detection device from the first through hole.

15. The automatic dosing device according to any one of claims 12-14, wherein, Further comprising: An activity display screen is arranged on the shielding box, and the activity display screen is located outside or inside the shielding box, and the activity display screen is in communication connection with the activity detection device.

16. The automatic dosing device according to any one of claims 1-15, wherein, Further comprising: a waste shielding container, the shielding box is further formed with a second shielding cavity in communication with the first shielding cavity, and the waste shielding container is arranged in the second shielding cavity.

17. The automatic dosing device according to claim 16, wherein, Further comprising: A second shielding cover is arranged on the shielding box, and the shielding box is formed with a communication port in communication with the first shielding cavity and the second shielding cavity, and the second shielding cover is used for opening or closing the communication port.

18. The automatic dosing device according to claim 17, wherein, The second shielding cavity is located below and adjacent to the first shielding cavity, the bottom wall of the first shielding cavity is formed with the communication port, and the second shielding cover is located in the first shielding cavity.

19. The automatic dosing device of claim 16, wherein, The shielding box is provided with a shielding door, the second shielding cavity is formed with a taking and placing port, and the shielding door is used for opening or closing the taking and placing port.

20. The automatic dosing device according to any one of claims 1-19, wherein, The shielding box is formed with an observation port corresponding to the first shielding cavity, and the observation port is provided with a shielding glass.

21. The automatic dosing device according to any one of claims 1-20, wherein, Further comprising: A shielding tank is adapted to be placed in the first shielding cavity, and the shielding tank is used for storing the corresponding reagent bottle.

22. The automatic dosing device according to claim 21, wherein, A plurality of shielding tanks are adapted to be placed in the first shielding cavity.

23. The automatic dosing device according to claim 4 or 5, wherein, Further comprising: A controller is in communication connection with the reagent injection equipment, and the controller is configured to control the operation of the reagent injection equipment.

24. The automatic dosing device according to claim 23, wherein, The outer side of the shielding box is formed with a storage groove, and the storage groove is used for placing the controller.

25. The automatic dosing device according to claim 24, wherein, Further comprising: An operation table is fixed to the shielding box, and the operation table is located outside and on one side of the first shielding cavity, and the top wall of the operation table is formed with the storage groove which is inclined along the height direction of the automatic drug delivery equipment.

26. The automatic dosing device according to any one of claims 23-25, wherein, Further comprising: a loss prevention structure connected with the controller and the shielding box.

27. The automatic dosing device according to any one of claims 1-20, wherein, Further comprising: An emergency stop operation key and an operation table are fixed to the shielding box, and the operation table is located outside and on one side of the first shielding cavity, and the top wall of the operation table is provided with the emergency stop operation key, and the emergency stop operation key is configured to cut off the connection between the automatic drug delivery equipment and the power supply.

28. The automatic dosing device according to any one of claims 1-20, wherein, Further comprising: A power operation key and an operation table, the operation table is fixedly arranged on the shielding box, and the operation table is located outside and one side of the first shielding cavity, the operation table top wall of the operation table is provided with the power operation key, and the power operation key is configured to control the automatic drug delivery device to be powered on or powered off.

29. The automatic dosing device according to any one of claims 1-20, wherein, Further comprising: A disinfection device arranged in the first shielding cavity, the disinfection device is selectively turned on or turned off.

30. The automatic dosing device according to claim 29, wherein, The disinfection device is fixedly arranged on the side wall of the first shielding cavity.

31. The automatic dosing device according to claim 29 or 30, wherein, Further comprising: A disinfection operation key configured to turn off or turn on the connection of the disinfection device and the power supply.

32. The automatic dosing device according to claim 31, wherein, Further comprising: An operation table fixedly arranged on the shielding box, and the operation table is located outside and one side of the first shielding cavity, the operation table top wall of the operation table is provided with the disinfection operation key.

33. The automatic dosing device according to any one of claims 1-20, wherein, Further comprising: A table plate arranged on the outer surface of the shielding box, and the table plate is used to place objects.

34. The automatic dosing device of claim 33, wherein, The table plate is movably arranged on the shielding box, and the table plate has a first position and a second position, when the table plate is located at the first position, the table plate is parallel to the horizontal plane, and when the table plate is located at the second position, the table plate is perpendicular to the horizontal plane.

35. The automatic dosing device of claim 34, wherein, Further comprising: a support structure connected between the table plate and the shielding box, and the support structure supports the table plate when the table plate is located at the first position.

36. The automatic dosing device according to claim 35, wherein, The table plate has opposite first and second ends, the first end is rotatably arranged on the shielding box, a lower surface of the table plate is formed with a mounting beam, the mounting beam is formed with a strip-shaped limiting hole extending along the arrangement direction of the first and second ends, and the support structure includes a support rod, one end of the support rod is rotatably connected with the shielding box, and the other end of the support rod is assembled in the strip-shaped limiting hole and is movable along the strip-shaped limiting hole.

37. The automatic dosing device according to any one of claims 1-20, wherein, A second through hole communicating with the first shielding cavity is formed in the side wall of the first shielding cavity, and the reagent injection assembly penetrates through the second through hole.

38. The automatic dosing device according to any one of claims 1-20, wherein, The shielding box is connected with casters.

39. The automatic dosing device according to any one of claims 1-20, wherein, The shielding box is provided with a handle.

40. The automatic dosing device according to claim 5 or 6, wherein, The outer surface of the reagent injection device is fixedly provided with a plurality of fixing seats, and the plurality of fixing seats are respectively used to mount the manifold pipeline and the plurality of delivery pipelines.

41. The automatic dosing device according to claim 5 or 6, wherein, At least one of the manifold pipeline and the plurality of delivery pipelines is provided with a bubble detection piece, and the bubble detection piece is fixedly arranged on the reagent injection device.

42. The automatic dosing device according to claim 5 or 6, wherein, The manifold pipeline is provided with a flow detection piece, and the flow detection piece is fixedly arranged on the reagent injection device.

43. The automatic dosing device according to claim 5 or 6, wherein, The manifold pipeline is provided with an air filter.

44. The automatic dosing device of claim 43, wherein, Further comprising: A bracket seat fixedly arranged in the first shielding cavity, and an upper surface of the bracket seat is at least partially formed with a mounting inclined surface, and the air filter is mounted on the mounting inclined surface.

45. The automatic dosing device of claim 44, wherein, Further comprising: A fixing frame located in the first shielding cavity and fixedly arranged on the shielding box, and the bracket seat is fixedly arranged on the fixing frame.

46. The automatic dosing device of claim 45, wherein, Further comprising: A fixing seat, and a plurality of fixing seats are fixedly arranged on the surface of the fixing frame, and the plurality of fixing seats are respectively used to mount the manifold pipeline and the plurality of delivery pipelines.

47. The automatic dosing device according to claim 5 or 6, wherein, The manifold pipe and at least one of the plurality of delivery pipes are configured as hoses.

48. The automatic dosing device of claim 23, wherein, The reagent injection assembly further comprises: A liquid taking device, the liquid taking device and the reagent delivery device are arranged in the first shielding cavity, the liquid taking device is used for placing the corresponding reagent bottle, and the liquid taking device cooperates with the reagent delivery device to drive the reagent delivery device to insert or pull out the corresponding reagent bottle.

49. The automatic dosing device of claim 48, wherein, The reagent delivery device has a needle, the liquid taking device has a moving part and a placing groove, the moving part and the placing groove are opposite and spaced apart, the placing groove is used for storing the corresponding reagent bottle, and the needle is detachably assembled in the moving part, and the moving part is moved towards or away from the placing groove to drive the needle to insert or pull out the corresponding reagent bottle.

50. The automatic dosing device of claim 48, wherein, The controller is in communication connection with the liquid taking device, and the controller is configured to control the operation of the liquid taking device.

51. The automatic dosing device of claim 50, wherein, Further comprising: A fixing frame, the fixing frame is located in the first shielding cavity and fixedly arranged on the shielding box, and part of at least one of the liquid taking device, the reagent injection device and the reagent delivery device is fixedly arranged on the fixing frame.

52. The automatic dosing device according to any one of claims 1-20, wherein, Further comprising: An alarm device, the alarm device is used for sending alarm information. An alarm device, the alarm device is used for sending alarm information.

Images